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Short summary 
 
 
Silica nanoparticles show promising characteristics as oral drug delivery carriers. This 
application implies a close contact with biological systems, therefore it is essential to 
investigate the cellular binding, uptake and transport properties of nanoparticles. Furthermore, 
their oxidative and cytotoxic potential has to be evaluated. A novel non-invasive assay for the 
combined determination of cytotoxicity and oxidative stress exhibited that unmodified 
nanoparticles with a size up to 84 nm caused a size-, time- and concentration-dependent 
cytotoxic effect in Caco-2 cells. In contrast, larger and poly ethylene glycol-modified 
nanoparticles provoked no deleterious effects. However, none of these particles showed an 
oxidative potential. Cytotoxicity studies correlated with cell association, uptake and transport 
experiments: Nanoparticles, which demonstrated a cytotoxic effect, were also in a strong 
association with Caco-2 cells or were even internalized. Thereby, the novel labelling of 
nanoparticles with propidium iodide (PI) allowed a clear distinction between adsorbed and 
internalized nanoparticles in a quantitative way which facilitated the identification of cellular 
mechanisms involved in the uptake of nanoparticles. Furthermore, silica nanoparticles could 
function as drug carriers for the membrane-impermeable compound PI. Free PI molecules 
were not able to enter Caco-2 cells, whereas nanoparticle bound PI was internalized time-
dependently.  
 
  
Kurzzusammenfassung 
 
 
Silika-Nanopartikel zeigen vielversprechende Eigenschaften als orale Arzneistoffcarrier. 
Diese Anwendung impliziert einen engen Kontakt zwischen Partikeln und biologischen 
Systemen. Daher ist es unerlässlich die Assoziierung und Aufnahme von Partikeln zu 
untersuchen sowie ihr zytotoxisches und oxidatives Potential zu bewerten. Eine innovative 
Methode zur kombinierten Detektion von Zytotoxizität und oxidativem Stress zeigte, dass 
unmodifizierte Nanopartikel bis zu einer Größe von 84 nm einen größen-, zeit- und 
konzentrationsabhängigen zytotoxischen Effekt auf Caco-2 Zellen aufwiesen. Größere sowie 
Polyethylenglykol-modifizierte Partikel hatten dagegen keine zellschädigende Wirkung. Ein 
oxidatives Potential konnte von keinem der Partikel verzeichnet werden. Diese 
Toxizitätsstudien korrelierten mit zellulären Assoziierungs- und Aufnahmeexperimenten. 
Nanopartikel, die einen zytotoxischen Effekt zeigten, demonstrierten auch eine starke 
Assoziierung mit Caco-2-Zellen oder wurden sogar in diese aufgenommen. Die Markierung 
der Partikel mit Propidiumiodid (PI) ermöglichte dabei eine deutliche Unterscheidung 
zwischen adsorbierten und aufgenommenen Nanopartikeln. Die Identifizierung der zellulären 
Mechanismen, die in der partikulären Aufnahme involviert sind, wurde dadurch erleichtert. 
Silika-Nanopartikel fungierten zudem als Carrier für das membran-impermeable PI. Freies PI 
wurde nicht in Caco-2-Zellen aufgenommen, wohingegen partikelgebundenes PI zeitabhängig 
internalisiert wurde. 
 
  
1 
General introduction 
 
 
1.1 SILICA NANOPARTICLES AS NOVEL DRUG CARRIERS 
 
The intensive research and discovery of novel drugs such as peptides, proteins, plasmids, 
antibodies and nucleic acids require new drug delivery technologies. Thereby, the usage of 
nanomaterials allows various creative applications. They can improve the bioavailability of 
poorly water-soluble drugs, prolong the half-life of drug systemic circulation, release drugs at 
a sustained rate, deliver drugs in a targeted manner and therefore, minimize side effects. 
Furthermore, this new technology allows the administration of two or more drugs with e.g. 
different water solubilities simultaneously in combinatory therapy and thus suppresses drug 
resistance. In addition, nanoparticles as drug carrier offer the usage of more effective and 
convenient routes of administration (e.g. the oral route), minimize therapeutic toxicity, extend 
the product life cycle and reduce health-care costs (Zhang et al., 2008). Numerous 
nanoparticle-based drug formulations and diagnostic agents had been already developed, e.g. 
for the treatment of cancer, diabetes, pain, asthma, allergy and infections (Brannon-Peppas & 
Blanchette, 2004; Kawasaki & Player, 2005). Besides therapy, nanomaterials can be also used 
as diagnostic tools. They allow the detection of disease markers in the molecular scale and 
identify abnormalities such as virus fragments or cancerous cells (Zhang et al., 2008). All 
these applications can be summarized in the term nanomedicine (Figure 1.1). Thereby, 
nanoparticles show various therapeutic potentials in different medical fields such as oncology 
or immunology (Farokhzad & Langer, 2006). Hitherto, about 20 nanoparticle-based 
formulations are in clinical use referring to the promising properties of these novel materials 
(Danson et al., 2004; Gabizon et al., 2006; Gradishar, 2006; Valle et al., 2010). Therefore, 
nanomedicine is expected to become a well-established term in modern medicine.  
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Figure 1.1: Applications and research aims in nanomedicine (modified from Liu et al., 2007).  
 
In this regard, silica nanoparticles exhibit various advantages and show a great promise in 
many medical and pharmaceutical applications. Silica is a non-toxic compound which is 
already used as food additive or as carrier material in tablets (Barbé et al., 2004). Silica 
nanoparticles can be easily surface modified with several molecules to improve and target the 
cellular uptake over surface chemistry (Chung et al., 2007; Kneuer et al., 2000; Kneuer et al., 
2000). A surface modification of nanoparticles, e.g. with poly ethylene glycol (PEG) extends 
the residence time of these carriers in the blood. Thereby, the effect of PEG is based on the 
defilade of nanoparticles over surface chemistry, hence avoiding a clearance by the 
phagocytic system (Owens & Peppas, 2006; Roberts et al., 2002). Furthermore, PEG shows 
stabilizing properties on the nanoparticle surface due to a steric barrier formed by PEG chains 
(Behrens et al., 2002; Tobio et al., 2000). Further advantages of silica nanoparticles are their 
high hydrophilicity and insensitivity to microbial attack. In addition, they do not show any 
swelling or porosity changes within alteration in pH which becomes very important with 
regard to an oral application (Jain et al., 1998). Silica nanoparticles can be easily labelled with 
fluorescence dyes, which is essential for the investigation of their behaviour in cell culture 
systems. Dye-doped silica nanoparticles can be prepared by two general synthetic routes: the 
Stöber and microemulsion process. The Stöber synthesis was introduced in 1968 by Stöber 
and Fink. It is a one-pot synthesis that is performed under alkaline conditions in an 
ethanol/water mixture. Therefore, potentially toxic organic solvents or surfactants can be 
avoided (Rossi et al., 2005; Stöber & Fink, 1968). The method allows a controlled generation 
of spherical silica particles with uniform sizes ranging from 50 to 2000 nm in diameter. 
During microemulsion preparation, silica nanoparticles were prepared using a water in oil 
emulsion system that employs a water-soluble amine as catalyst and tetraethylorthosilicate 
(TEOS) as a silica source.  
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In recent years various studies proved the properties of silica nanoparticles as oral drug or 
gene carrier (Bharali et al., 2005; Fuller et al., 2008; Gemeinhart et al., 2005; Manzano et al., 
2009; Moulari et al., 2008; Simovic et al., 2010; Slowing et al., 2008; Tan et al., 2010). 
Hollow mesoporous silica nanoparticles had been used as drug carriers for fluorescein 
isothiocyanate (FITC), which served as a model substance. FITC encapsulated in silica 
nanocapsules was released more slowly than free FITC indicative for a controlled release of 
the dye (Liu et al., 2007). Further studies showed that silica nanoparticles are also useful as 
gene carriers. Plasmids bound to amino-functionalized silica nanoparticles were completely 
protected from enzymatic digestion in human epithelial cancer cells (Kneuer et al., 2000; Roy 
et al., 2005). Furthermore, it was shown that organically modified silica nanoparticles can be 
effectively used to introduce genes into neuronal cells in vivo (Bharali et al., 2005). Silica 
nanoparticles could also serve as carriers for anticancer drugs such as doxorubicin. It was 
reported, that mesoporous silica nanoparticles (MSN) release the drug over a period of 
20 days in a constant rate (Barbé et al., 2004). Furthermore, MSN were able to enhance the 
delivery of the hydrophobic anticancer drug paclitaxel to pancreatic cancer cells (Xia et al., 
2009) and allowed a target delivery of the chemotherapeutic agent methotrexate (MTX). Free 
MTX caused apoptosis in cancer cells as well as in healthy cells. In contrast, MTX bound to 
nanoparticles induces cell death only in cancer cells but not in normal tissue (Rosenholm et 
al., 2010).  
 
To evaluate silica nanoparticles as oral drug delivery system, it is important to determine their 
cellular uptake and localization. Especially, their distribution within the cell is an essential 
indication for the future application spectrum. Unmodified silica nanoparticles sized between 
40 and 5000 nm were able to enter human epithelial cells in a size-dependent way. The 
qualitative analysis via confocal laser scanning microscopy (CLSM) demonstrated a clear 
penetration into the cytoplasm. For silica nanoparticles sized between 40 and 70 nm a nuclear 
localization was observed as well (Chen & Mikecz von, 2005). In the field of gene delivery 
the uptake of nanoparticles into the cell nucleus becomes very important because the cell 
nucleus contains the gene expression machinery and monitors the genetic material of a cell. 
Thus, it represents the target for delivered genetic material such as plasmids or antisense 
oligonucleotides (Bharali et al., 2005; Gemeinhart et al., 2005; Slowing et al., 2008). These 
results in fundamental research underline the high potential of silica nanoparticles as oral drug 
or gene carrier.  
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Another frequently discussed topic is the application of nanoparticles to inflamed tissue in 
inflammatory bowel disease (IBD) (Lamprecht et al., 2001; Lamprecht et al., 2005; Moulari et 
al., 2008; Nakase et al., 2000; Nakase et al., 2001). Most drugs which are used for the 
treatment of IBD are delivered also to non-inflamed tissue. A targeted delivery exclusively to 
the inflamed tissue would decrease side effects and improve the therapeutic success. 
Polystyrene micro- and nanoparticulate carrier were shown to accumulate size-dependently in 
inflamed colonic mucosa (Lamprecht et al., 2001). Also silica nanoparticles exhibit a sixfold 
higher accumulation in inflamed tissue than in the healthy control tissue. The successful 
delivery of a drug to inflamed colonic cells could be demonstrated using 5-Amino salicylic 
acid (5ASA) loaded silica nanoparticles. 5ASA is used to treat inflammation in ulcerative 
colitis and Crohn’s disease. 5ASA-loaded silica nanoparticles with a concentration of 
25 and 50 mg/kg caused a higher decrease in inflammatory than free 5ASA at a concentration 
of 100 mg/kg (Moulari et al., 2008).  
 
The design of silica nanoparticles as drug or gene carriers has to follow several requirements. 
The composition of the particles must be biodegradable, biocompatible and nontoxic, so that 
they can be used in human therapy. The particle size must be suitable for the administration 
via different routes to enter the body and reach the biological target site. Furthermore, also the 
biodistribution should adjust to the therapeutic application. Finally, silica nanoparticles must 
be loaded with drug molecules, whereby the drug should be released in a controlled manner 
once it reaches the target organ e.g. a tumour (Vauthier & Couvreur, 2007; Zhang et al., 
2008). Further developments lead to more complex oral delivery systems such as silica-lipid 
hybrid (SLH) microcapsules for the improved delivery of poorly soluble drugs. The system 
combined the solubilising effect of lipids with the stabilising effect of silica nanoparticles. 
This novel drug carrier was able to increase the oral availability of the model drug celecoxib 
from 62% to 93-100% when bound to SLH microcapsules (Tan et al., 2009). In this context 
various other silica-based formulations exist to control and facilitate drug dissolution 
(Sanganwar & Gupta, 2008). Table 1.1 summarizes the composition of silica nanoparticles as 
drug carriers.  
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Table 1.1: Summary of different types of nanoparticulate drug carriers (modified from Vauthier & Couvreur, 
2007; Liu et al., 2007; Tan et al., 2009).  
Nanoparticulate drug 
carrier 
Definition Schematic 
illustration 
Carrier nanoparticles  Drug molecules are adsorbed to the surface of 
the nanoparticles.  
 
 
Oil-containing 
nanocapsules 
Nanoparticles with an encapsulated oil droplet 
surrounded by a silica shell. 
 
 
Water-containing 
nanocapsules 
Nanoparticles with an encapsulated water 
droplet surrounded by a silica shell. 
 
 
Mesoporous 
nanocapsules 
Hollow mesoporous nanocapsules with 
encapsulated drugs. 
 
 
Silica-lipid hybrid 
microcapsules 
Silica-lipid hybrid microcapsules with an 
internal porous matrix structure with 
encapsulated drugs. 
 
 
Stealth carriers Modification of the nanoparticle surface with 
e.g. PEG will reduce recognition by the 
immune system and increase plasma stability.  
 
 
Targeted carriers Drug-targeted system with a targeting ligand 
(e.g. antibodies) on the nanoparticle surface. 
 
 
 
 
 
1.2 OVERCOMING THE INTESTINAL BARRIER 
 
Oral drug delivery is the most convenient route for the administration of drugs because it has 
the advantage of avoiding discomfort, pain and infections which can be caused by injectable 
dosage forms. However, most drugs are difficult or unable to be delivered orally because of 
their low bioavailability due to their poor stability in the gastrointestinal tract and their low 
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membrane permeation over the intestinal barrier. For systemic absorption it is indispensable 
that drug molecules resist the acid (~pH 3) and enzymatic environment of the stomach and 
finally cross the intestinal epithelial cells to reach the general circulation and the target sites 
(Figure 1.2).  
 
 
Figure 1.2: Biological barriers that influence oral bioavailability. Orally administered drugs have to be soluble 
and stable in the acid and enzymatic environment of the stomach (1) and have to cross the epithelium of the 
small intestine via an active or passive uptake to reach the blood circulation (2). Thereby efflux systems such as 
P-gp and enzymes (CYPs) hinder the passage. The first pass mechanism of the liver that eliminates xenobiotic 
substances is another critical obstacle (3). Figure was modified from Dave Carlson Illustration, Colorado, USA.  
 
This process, however, is limited by various physical and biochemical barriers which 
normally protect the organism from toxins, antigens and microorganisms. The membrane of 
the intestinal epithelium builds a tight physical barrier which is composed of a single layer of 
columnar cells that are connected by tight junctions to form a tight membrane. Drug 
molecules or drug carriers such as nanoparticles can cross the gastrointestinal barrier via 
different pathways using paracellular passage and endocytotic or lymphatic uptake. The 
uptake between intestinal epithelial cells is mostly the preferred way of very small 
nanoparticles of up to 50 nm. Larger particles of sizes up to 500 nm are absorbed by intestinal 
enterocytes through endocytosis whereas microparticles (<5 µm) are taken up by M cells of 
the Peyer’s patches (Florence, 2005; Hamman et al., 2005; LeFevre et al., 1978; Liu et al., 
1          General introduction  7 
 
 
2007; Sanders & Ashworth, 1961; Venkatesan et al., 2005) (Figure 1.3). Efflux systems such 
as the P-glycoprotein (P-gp) demonstrate a further barrier function. P-gp is localized in the 
apical membrane and pumps compounds from within the cell back into the intestinal lumen. 
Substrates of P-gp are various chemical molecules such as cytostatics, HIV protease 
inhibitors, immunsuppressors and antibiotics (Gottesman et al., 2002; Hunter et al., 1993). 
 
 
Figure 1.3: Uptake of nanoparticles at the intestinal epithelium. This epithelium consists of specialised antigen 
sampling M cells which possess a reduced number of microvilli and a pocket staying in contact with 
lymphocytes and macrophages. Nanoparticles are largely prevented from passing between epithelial cells by 
tight junctions. After the adherence to the apical membrane of M cells, nanoparticles cross the apical membrane 
and are delivered into the cells and subsequently are disseminated by the lymphatics (modified from Clark et al., 
2001).  
 
In recent years, the term “chemotherapy at home” presents a new concept of chemotherapy 
and purpose for the development of orally bioavailable cytostatics. This innovation would 
improve the life quality of cancer patients remarkably (Ajani & Takiuchi, 1999; Bottomley, 
2002; DeMario et al., 1999; Feng, 2004). The difficulties are that most anticancer drugs are 
orally not or just minimally bioavailable, e.g. the oral bioavailability of the cytostatic 
paclitaxel is less than 1% of the administered concentration. This low absorption in the 
gastrointestinal tract is based on the first-pass elimination by the cytochrome P450 and the 
high affinity of paclitaxel to P-gp. The role of P-gp in that context was demonstrated in a 
study using wild-type and P-gp knockout mice. As a result, an increased oral uptake of 
paclitaxel could be observed in mice lacking P-gp (Sparreboom et al., 1997). The additional 
application of the P-gp inhibitor cyclosporine resulted in a 10-fold higher oral absorption of 
paclitaxel (Meerum Terwogt et al., 1999). In this context, further experiments showed that 
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doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by 
inhibiting P-gp (Dong et al., 2009). The application of TPGS, a water soluble vitamin E 
derivative, which is able to inhibit the P-gp mediated drug transport, represented a further 
improvement of drug delivery into intestinal cells (Collnot et al., 2006; Win & Feng, 2005). 
These findings exhibit the high demand of new strategies for the oral delivery of various drug 
molecules with low stability and bioavailability. However, the delivery of anticancer drugs to 
tumours is still a challenge. In this context, silica nanoparticles provide innovative and 
promising characteristics as drug carriers and present an attractive drug delivery system. 
Tumours contain a high density of abnormal blood vessels that are poorly differentiated with 
an aberrant branching. Furthermore, these tissues have an enhanced permeability and 
retention effect due to a decreased rate of clearance caused by the lack of functional lymphatic 
vessels in the tumour. Therefore, an increased accumulation of macromolecules as well as 
nanoparticles could be demonstrated (Allen & Cullis, 2004; Conti et al., 2006).  
 
A widespread in vitro model for the investigation of oral bioavailability is the human colon 
adenocarcinoma cell line Caco-2. These cells form a polarized monolayer with an apical 
brush border morphologically comparable to that of the human small intestinal epithelium. 
Caco-2 cell express tight junctions, microvilli and a number of enzymes and transporters that 
are characteristic for enterocytes (e.g. P-gp). When cultured on permeable filter membranes, 
Caco-2 cells form a polarized epithelial cell monolayer that provides a physical and 
biochemical barrier to the passage of ions and small molecules. Caco-2 cells are widely used 
as an in vitro model to predict the absorption of orally administered drugs. The in vitro/in vivo 
correlation is well established and shows a high accordance (Artursson et al., 1997; Artursson 
et al., 2001; Chen et al., 2002; Hidalgo et al., 1989; Hughes et al., 1987). 
 
 
 
1.3 CYTOTOXICITY AND OXIDATIVE STRESS CAUSED BY 
NANOPARTICLES 
 
Silica-based materials with defined structures and surface properties are known to be 
biocompatible. Silica is used to enhance the biocompatibility of various drug delivery systems 
such as magnetic nanoparticles, biopolymers and micelles (Allouche et al., 2006; Arruebo et 
al., 2006; Huo et al., 2006). Microscopic analysis showed normal cell morphology after an 
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uptake of mesoporous silica nanoparticles. Furthermore, growth rates of cells exposed to 
silica nanoparticles demonstrated no difference to the ones of control cells grown in the 
absence of silica nanoparticles (Slowing et al., 2006; Slowing et al., 2008). A long-term 
biocompatibility study exhibited that silica implants caused no toxic effects within a period of 
42 days (Kortesuo et al., 1999). 
 
However, the growing biomedical and pharmacological applications of silica nanoparticles 
call for the importance to investigate their influence on cells as their uptake implies a close 
contact between nanoparticles and the biological systems. Therefore, a detailed evaluation of 
the cytotoxic potential of nanomaterials is required. In this course, nanotoxicology is a rising 
sector in nanotechnology. Institutions such as the European Commission or the European 
Food Safety Authority published scientific opinions about the potential risk of nanomaterials 
in cosmetics or food which suggest treating nanomaterials as new chemicals from a risk-point 
of view  (EFSA, 2009; SCCP, 2007).  
 
Hitherto, the molecular mechanism of nanoparticulate induced cytotoxicity is not fully 
understood. It is assumed that cytotoxicity is caused by cellular injuries through a variety of 
mechanism such as membrane peroxidation, glutathione depletion, mitochondrial dysfunction 
and DNA damage (Tao et al., 2009). Especially nanoparticulate induced oxidative stress 
raises suspicion affecting all types of biological molecules including lipids, proteins, 
carbohydrates and nucleic acids. Therefore, oxidative stress is one of the most important 
toxicity mechanism related to the exposure of nanoparticles (Eom & Choi, 2009; Green & 
Howman, 2005; Shvedova et al., 2003). 
 
In various studies an increase in reactive oxygen species (ROS) could be detected 
simultaneously with a decrease in cell viability after incubation with silica nanoparticles (Eom 
& Choi, 2009; Park et al., 2008; Wang et al., 2009). A rising amount of ROS is often 
associated with a decrease in glutathione and an enhanced activity of antioxidant enzymes 
such as superoxide dismutase or heme oxygenase-1, which indicated an oxidative potential of 
silica nanoparticles. Inflammation signal and apoptosis markers can be increased as well. 
Further studies supposed that the acute cytotoxicity is primarily originated from the cellular 
internalization of nanoparticles rather than physical damage on cellular membranes (Yang et 
al., 2009). Furthermore, it is expected that the smaller the size, the stronger the observed 
toxicity is (Oberdorster et al., 2005). In a study of Wang et al., nanoparticles with a size of 
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20 nm showed a higher decrease in cellular viability than 50 nm particles with a 
simultaneously higher increase of ROS in human embryonic kidney cells (Wang et al., 2009). 
However the relationship between the physico-chemical properties of nanoparticles and their 
toxicities seems to be much more complicated than just a matter of their size and surface area 
(i.e. shape, charge, concentration, etc), but the debate is still ongoing (Hussain et al., 2005; 
Sayes et al., 2005). 
 
 
 
1.4 AIM OF THE THESIS 
 
The aim of this thesis was to investigate the interaction between silica nanoparticles and the 
human intestinal epithelial cell line Caco-2. Thereby, the cytotoxic and the oxidative potential 
as well as the uptake and transport characteristics of these particles should be explored.  
 
One focus was stressed on the establishment of novel alternatives to standardized method for 
the detection of oxidative stress and cytotoxicity in vitro. The measurement principles of the 
standardized techniques often interfere with nanoparticles and prohibited their usage for these 
applications. In their role as potential drug carriers, silica nanoparticles are supposed to come 
into close contact with biological systems, thus it is essential to have a dependable assay to 
evaluate the toxicity of nanoparticles.  
 
Another aim of this thesis was to allow a quantification of the cellular uptake of nanoparticles. 
Hitherto, the nanoparticulate uptake was mostly determined via microscopic techniques such 
as confocal laser scanning microscopy or transmission electron microscopy, which makes a 
comparison between single studies very difficult. Therefore, a quantitative assay for the 
determination of the quantification of nanoparticles should be established.  
 
Based on this novel experimental design, the uptake behaviour of silica nanoparticles with 
different sizes and surface modifications should be explored. Furthermore, the endocytotic 
mechanisms involved in the uptake of these nanoparticles should be identified (Figure 1.4). 
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Figure 1.4: Working flow chart of the present thesis.  
  
  
2 
Characterization of fluorescently-labelled 
silica nanoparticles in physiological buffers 
and cell culture media 
 
 
Fluorescently-labelled silica nanoparticles were prepared by the Leibniz Institute of New 
Materials (INM, Saarbrücken, Germany) and were stored highly concentrated in an aqueous 
solution stabilized with acetic acid to a pH of ~5. For their use in in vitro cell culture 
experiments, these nanoparticles had to be dispersed in physiological buffers or cell culture 
media. The tendency of nanoparticles to agglomerate is sensitive to ingredients such as 
bivalent ions (e.g. Ca2+ or Mg2+). Therefore, the dispersion of nanoparticles in these isotonic 
solutions as well as their stability had to be explored before performing in vitro experiments. 
The alteration in size and ζ potential of a nanoparticle gives information about the 
nanoparticulate behaviour in physiological media and were determined via dynamic light 
scattering or electrophoretic light scattering using the Zetasizer Nano Zs (Malvern 
Instruments, Herrenberg, Germany).  
 
 
 
2.1 INTRODUCTION 
 
The upcoming usage of nanostructured biomaterials in pharmaceutical or medical purposes 
requires an improved knowledge of the biological interaction of nanomaterials with cells or 
tissues. Therefore, in vitro experiments are essential. These assays require the compatibility 
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and stability of nanoparticles in physiological buffers or media. As a consequence, 
nanoparticles have to be dispersed in isotonic solutions with a pH of 7.4, where they interfere 
with bivalent ions (typically magnesium or calcium) and protein mixtures. Due to their large 
surface area/volume ratio, nanoparticles show a strong tendency to agglomerate and to adsorb 
proteins., The knowledge of protein adsorption is very important because the adsorption of 
blood proteins in vivo will affect the cellular uptake and biochemical activity (Patil et al., 
2007; Schulze et al., 2008). 
 
Recent studies already demonstrated aspects of nanoparticle dispersion and protein 
adsorption. The addition of proteins such as bovine serum albumin (BSA) to nanoparticles 
reduced the ζ potential from ~55 mV to ~18 mV indicative for a strong protein adsorption to 
the particle surface. Furthermore, a binding to proteins resulted in an accelerated clearance by 
macrophages which avoid nanoparticles from reaching their biological target sites (Patil et al., 
2007). For this purpose, besides unmodified silica nanoparticles, poly ethylene glycol (PEG)-
modified silica nanoparticles were characterized in this study as well. Thereby, it could be 
possible to increase the circulation time of nanoparticles in the blood stream by minimizing 
and eliminating protein adsorption due to the characteristics of PEG. PEG is a polyether 
compound which is known to reduce reticuloendothelial clearance, the uptake by 
macrophages, recognition by the immune system and the degradation by proteolytic enzymes. 
It shows stabilizing properties due to a steric stabilization as well (Roberts et al., 2002; 
Behrens et al., 2002; Tobio et al., 2000).  
 
 
 
2.2 AIM OF THE STUDY 
 
In the present study, fluorescently-labelled nanoparticles with different sizes and surface 
modifications were characterized concerning their behaviour in different media or buffer over 
time by investigation of their variation in size and ζ potential. The absorption of BSA as 
model protein was explored as well. For a better comprehensibility and clarity only exemplary 
results are presented, especially because nanoparticles with analogue characteristics behaved 
similarly.  
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The aim of this study was to determine the size alteration and the stability of fluorescently-
labelled silica nanoparticles in physiological buffers and cell culture media (+/- proteins). 
Furthermore, the ζ potential as well as the adsorption of BSA should be investigated. The 
characterization of the nanoparticles should help to establish a catalogue of different 
nanoparticles for various experimental approaches and questions.  
 
 
 
2.3 MATERIALS AND METHODS 
 
2.3.1 Silica nanoparticles 
Amorphous silica nanoparticles were received from the Leibniz Institute of New Materials 
(INM, Saarbrücken, Germany) where they had been prepared by Stöber synthesis. 
Synthesized nanoparticles were either unmodified or additionally surface-modified with 
amino-ethyl-3-aminopropyl-trimethoxysilan (DIAMO) or poly ethylene glycol (PEG) chains 
with a molecular weight of 750 g/mol. Transmission electron microscopy (TEM) 
measurements were performed as a visual control. Figure 2.1 shows exemplary TEM images 
of unmodified and PEG-modified silica nanoparticles with different sizes.  
 
For fluorescence detection, nanoparticles were matrix-loaded with the fluorescent dye 
rhodamine B-isothiocyanate (RITC). Thereby, the silica matrix served as a protective shell 
limiting the effect of the outer environment to the fluorescent molecules. For further 
experiments, nanoparticles were surface-loaded with propidium iodide (PI). The choice of the 
fluorescence dyes was reasoned in different experimental approaches, which will be discussed 
in detail in the different chapters (compare to chapter 4 and 5). Nanoparticle names are 
composed of the particle size in HBSS, the surface modifications (D=DIAMO or P=PEG) and 
the fluorescence dye (RITC or PI).  
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N50                  N77        N94
 
Figure 2.1: TEM micrographs of silica nanoparticles with and without PEG-modification. (A) Unmodified 
nanoparticles, N50-RITC, 50 nm. (B) PEG-modified nanoparticles, N50-P-RITC, 55 nm. (C) Unmodified 
nanoparticles, N77-RITC, 77 nm. (D) PEG-modified nanoparticles, N77-P-RITC, 87 nm. (E) Unmodified 
nanoparticles, N94-RITC, 94 nm. (F) PEG-modified nanoparticles, N94-P-RITC, 97 nm. Bars=20 nm (A, B, E 
and F) or 50 nm (C and D). 
 
 
2.3.2 Materials and buffers 
Different silica nanoparticles were dispersed in phosphate buffered saline (PBS) (Table 2.1), 
Hank’s balanced salt solution (HBSS) (Table 2.2) with and without addition of 1% bovine 
serum albumin (BSA) or in Dulbecco’s modified eagle medium (DMEM) from Gibco 
(Karlsruhe, Germany) (Table 2.3). All buffers were adjusted to pH 7.4 by means of NaOH. 
Acrylic cuvettes for the determination of particles’ sizes were purchased from Sarstedt 
(Nümbrecht, Germany). Zeta folded capillary cuvettes for the measurement of the ζ potential 
were obtained from Malvern (Herrenberg, Germany).  
  
-PEG 
 
 
 
+PEG 
A C E 
B D F 
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Table 2.1: Composition of phosphate buffered saline (PBS). PBS were adjusted to pH 7.4 by means of NaOH. 
 
 
 
Table 2.2: Composition of Hank’s balanced salt solution (HBSS). HBSS were adjusted to pH 7.4 by means of 
NaOH. 
Ingredient Concentration  
NaCl 136.90 mM 
KCl 5.40 mM 
NaHCO3 4.26 mM 
Na2HPO4*7H2O 0.34 mM 
KH2PO4 0.35 mM 
Glucose 5.50 mM 
HEPES 10.00 mM 
CaCl2 1.26 mM 
MgCl2*6H2O 0.50 mM 
MgSO4*7H2O 0.40 mM 
 
  
Ingredient Concentration 
NaCl 129.00 mM 
KCl 2.50 mM 
Na2HPO4*7H2O 7.00 mM 
KH2PO4 1.30 mM  
 2          Characterization of silica nanoparticles  17 
 
 
Table 2.3: Composition of Dulbecco’s modified eagle medium (DMEM).  
Ingredient Concentration 
CaCl2*2H2O 1.80 mM 
Fe(NO3)3*9H2O 0.00025 mM 
MgSO4*7H2O 0.81 mM 
KCl 5.33 mM 
NaHCO3 44.05 mM 
NaCl 110.34 mM 
NaH2PO4*2H2O 0.92 mM 
D-Glucose 25.00 mM 
Phenol red 0.40 mM 
Amino acids 10.64 mM 
Vitamins 0.15 mM 
 
 
2.3.3 Measuring principle of the Zetasizer Nano ZS 
The Zetasizer Nano ZS allows the determination of the average hydrodynamic diameter by 
dynamic light scattering (DLS) and the ζ potential of nanoparticles by electrophoretic light 
scattering (ELS). DLS is a technique to characterize the diffusion of particles in solution. It 
measures Brownian motion and relates this to the size of the particles. Brownian motion is the 
random movement of particles due to forces resulted from the solvent molecules that 
surrounded them. The larger the particle, the slower is its Brownian motion because smaller 
particles move more rapidly. The size of a particle is calculated from the translational 
diffusion coefficient by using the Stokes-Einstein equation. Thereby, the measured 
hydrodynamic diameter refers to how a particle diffuses within a fluid. The principle of this 
measurement technique is based on a monochromatic laser beam that passes through a cuvette 
with a colloidal dispersion. Some of the light is uniformly scattered by the particles in all 
directions via Rayleigh scattering. The changing distances of the particles due to their 
Brownian motion causes interferences of the light scattered by neighbouring particles. The 
analysis of these occurred time-dependent fluctuations in the scattering intensity gives 
information about the speed of the particles in the solution. Using a diffusion coefficient, the 
hydrodynamic diameter of a nanoparticle could be determined (Malvern Technical Note).  
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The ζ potential is a physical property which is exhibited by any particle in suspension and is 
determined via ELS. It is the potential difference between the dispersion solution and the 
stationary layer of fluid attached to the particle, thereby it is measured at the slipping plane of 
particles. The liquid layer which surrounds a particle consists of two parts: an inner region 
(Stern layer) where the ions are strongly associated and an outer diffuse region, where ions 
are loosely bound. Within the diffuse layer there is a fictive boundary inside which the ions 
and particles form a stable unit. That would mean, if a particle moves, ions within the 
boundary move it. The potential at this boundary (=surface of hydrodynamic shear) is the 
ζ potential (Figure 2.2). The ζ potential is a measure for the degree of stability of a colloidal 
system. If all particles in suspension have a high negative or positive ζ potential, there will be 
no tendency for the particles to come together and so they repel each other. In contrast, if the 
particles have a low ζ potential, there will be no forces preventing the agglomeration of 
particles. The ELS measurement principle is based on the application of an electric field to the 
dispersed particles. By alternating the charge between the electrodes, the particles move back 
and forth between the electrodes at a velocity relative to their surface charge and the potential 
of the electrode (Malvern Technical Note).  
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Figure 2.2: Schematic illustration of the ζ potential (modified from Malvern Technical Note). 
 
 
2.3.4 Size, ζ potential and stability of nanoparticles in different buffers and media 
Stock solutions from the used fluorescently-labelled silica nanoparticles had concentrations 
ranging from 3.7 to 12.5 mg/ml. For the determination of the particles size as well as the 
ζ potential, particles were diluted in the respective dispersion buffer or media to a 
concentration of 100 µg/ml. Size measurements were performed at 37°C with an equilibration 
time of 120 seconds in disposable sizing cuvettes at the automatic mode. Every measurement 
was performed three times at different time points. For stability measurements, nanoparticle 
dispersions were stored at 37°C between the single measurements. For determination of the 
ζ potential, automatic measurements (10-100 runs) were performed at a temperature of 37°C 
and with an equilibration time of 120 seconds using the calculation model of Smoluchowski.  
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2.4 RESULTS AND DISCUSSION 
 
2.4.1 Alteration in the sizes of silica nanoparticle in different buffers and media 
Due to the alteration in the complexity of buffers and media, silica nanoparticles exhibited 
different behaviours. Thereby, unmodified RITC-labelled silica nanoparticles with different 
sizes could be dispersed in H2O as well as in PBS and HBSS. The dispersion in a cell culture 
medium e.g. DMEM with a very high complexity could be also performed without any 
agglomeration of nanoparticles (Figure 2.3).  
 
Figure 2.3: Dispersion of three unmodified RITC-labelled silica nanoparticles with different sizes (N30-RITC, 
N45-RITC and N77-RITC) in H2O, PBS, HBSS and DMEM. Bars present the mean ± SD of three 
measurements.  
 
Difficulties could be observed in the dispersion behaviour of nanoparticles with modified 
surfaces. Silica nanoparticles with adsorbed aminosilanes (DIAMO) showed a strong 
agglomeration in HBSS due to an interaction with bivalent ions in the buffer (Figure 2.4). The 
resulting aggregation was due to an electrostatic destabilization described by the Derjaguin-
Landau-Verwey-Overbeek theory (DLVO theory). This theory explains that the stability of 
colloidal systems is based on steric, electrostatic or van der Waals interactions between 
dispersed particles. A surface in an aqueous milieu is charged by dissociation of surface 
groups or by adsorption of charged molecules from the surrounding liquid. This arrangement 
results in the development of a wall surface potential which attract counterions from the 
environment and exclude ions with the same charge. Stable dispersions consist of a wall 
surface potential balanced by an equal but opposite charge of counterions. This potential can 
H2O PBS HBSS DMEM 
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be decreased via the adsorption of specific ions which results in a reduction of the interspace 
between single particles and a consequently agglomeration of the particles  (Zhang et al., 
2009). DIAMO-modified nanoparticles exhibited a positive ζ potential of 21.8 mV. The 
addition of bivalent cations such as Mg2+ and Ca2+ which are ingredients of HBSS caused a 
strong agglomeration of these particles due to an excess of positive charged molecules and a 
consequently reduced charge balance. In contrast, nanoparticles with the same size but 
without a DIAMO-modification could be dispersed in HBSS. Due to their negative ζ potential 
of -22.9 mV, unmodified silica nanoparticles were still in a balance with the surrounding 
milieu. 
 
Figure 2.4: Dispersion of RITC-labelled unmodified silica nanoparticles (N25-RITC; -22.9 mV) and DIAMO-
modified silica nanoparticles (N-25-D-RITC; +21.8 mV) in H2O and HBSS. Bars present the mean ± SD of three 
measurements.  
 
In contrast, PEG-modified nanoparticles could be dispersed in the same way as the 
corresponding unmodified nanoparticles. Thereby, the addition of PEG on the outer particle 
surface caused an increase in size of 0.7 nm to 10 nm (Figure 2.5). Furthermore, PEG-
modified nanoparticles showed no altered ζ potential.  
H2O HBSS 
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Figure 2.5: Size histograms of unmodified (black peaks) and the corresponding PEG-modified RITC-labelled 
nanoparticles (grey peaks). Particles were dispersed in HBSS buffer. (A) Unmodified nanoparticles N50-RITC, 
50 nm and PEG-modified nanoparticles N50-P-RITC, 55 nm. (B) Unmodified nanoparticles N77-RITC, 77 nm 
and PEG-modified nanoparticles N77-P-RITC, 87 nm. (C) Unmodified nanoparticles N94-RITC, 94 nm and 
PEG-modified nanoparticles N94-P-RITC, 97 nm.  
 
 
2.4.2 Stability of nanoparticles in different buffers and media 
For in vitro experiments a long-term incubation of cells with particles is sometimes necessary. 
Therefore, nanoparticles have to be dispersed in a cell-friendly milieu. Physiological buffers 
such as HBSS sustain the viability of cells for about 24 hours. If long-term experiment with 
longer incubation times should be performed, further supplements such as proteins, amino 
acids or vitamins are essential. All used RITC-labelled nanoparticles except DIAMO-
modified nanoparticles (Figure 2.4) were stable in HBSS over 24 hours (data not shown). The 
core-bound fluorescence dye RITC had no contact to the surrounding medium and therefore 
caused no interactions. In contrast, stability experiments with PI-labelled nanoparticles 
demonstrated that these nanoparticles often show no stability in HBSS over that period. PI-
labelled silica nanoparticles with different sizes (62 and 74 nm) could be dispersed in HBSS 
but showed a high agglomeration rate after a 24-hour-incubation (Figure 2.6). This 
A 
 
 
 
B 
 
 
 
C 
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agglomeration effect could be based again on the presence of bivalent ions in the buffer and 
their interaction with surface adsorbed PI molecules. Apparently, the charge balance could not 
be sustained for such a long period. However, time kinetic measurements of N21-PI, N34-PI 
and N84-PI nanoparticles demonstrated that these particles were stable for this period 
(Figure 2.6). 
 
Figure 2.6: Stability of PI-labelled unmodified nanoparticles with different sizes over 24 hours. Samples were 
measured directly after dispersion (0-h-incubation, black bars) or after an incubation of 24 hours at 37°C under 
standard cell culture conditions (24-h-incubation, grey bars). Bars present the mean ± SD of three measurements.  
 
A method for the solution of this stability problem was the application of ultrasonic which 
allows a separation of nanoparticles. Experiments showed that ultrasonic was able to separate 
agglomerated nanoparticles but did not help to stabilize these dispersions. Ultrasonic-treated 
nanoparticles even showed a higher agglomeration rate as untreated samples. The usage of 
ultrasonic with nanoparticles labelled with fluorescence dyes presents a further difficulty as 
these labellings can be released via this treatment.  
 
A further approach to stabilize nanoparticles is the stabilization via addition of bovine serum 
albumin (BSA). Various studies investigated the aspects of nanoparticle dispersion and 
protein adsorption including the binding enthalpy of proteins and the change of the ζ potential 
(Limbach et al., 2005; Patil et al., 2007; Schulze et al., 2008). The supplement of BSA to 
buffers or media resulted in a detectable size peak at ~8.4 nm which was based on BSA 
monomers (Figure 2.7, black peak). The measured diameter of nanoparticles was increased as 
well due to BSA monomers adsorbed to the particle surface creating a protein corona. 
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Unmodified N77-RITC nanoparticles exhibited a diameter of 108 nm ± 34.5 when dispersed 
in HBSS supplemented with 1% BSA (Figure 2.7, grey peak). In contrast, N77-RITC 
nanoparticles dispersed in HBSS without any addition of BSA showed a size of 
77.2 nm ± 0.53 (Figure 2.5 B). A further indication of a BSA coating was the alteration in 
ζ potential. N77-RITC nanoparticles dispersed in HBSS demonstrated a ζ potential of -28 mV. 
The addition of BSA into the medium caused a reduction of the ζ potential to -7.8 mV.  
 
 
Figure 2.7: Adsorption of BSA to the nanoparticle surface. Unmodified N77-RITC nanoparticles were dispersed 
in HBSS supplemented with 1% BSA. The grey peak demonstrated the size of N77-RITC nanoparticles coated 
with BSA. The black peak showed the size of free BSA in the solution. Bars present the mean ± SD of three 
measurements.  
 
The protein coating led to a sterical stabilization of the nanoparticle dispersions, which 
resulted in a reduction of particle agglomeration. Such a steric stabilization due to a coating 
with BSA had already been shown for gold, polymer and aluminium hydroxide nanoparticles, 
whereby these particles could be dispersed in media containing bivalent ions (Cedervall et al., 
2007; Deschaume et al., 2006; Lucocq & Baschong, 1986). The disadvantage of such a 
binding to proteins is that such particles are quickly cleared by macrophages in vivo and are 
not allowed to reach their target cells. Approaches to increase the particle circulation time, 
therefore try to eliminate protein adsorption. This approach would stay in contrast with the 
stabilization issue and lead to the point that particle stabilization via BSA or other proteins is 
not the best solution. However, an adsorption of proteins to the particle surface is not 
avoidable when nanoparticles, without a special surface modification, enter cells. As shown in 
figure 2.7 unmodified nanoparticles exhibited a strong BSA absorption which resulted in an 
increase in particle size of 30.8 nm. In contrast, nanoparticles modified with poly ethylene 
glycol (PEG) demonstrated only an increase in size of 6.15 nm (data not shown). The PEG-
modification avoids an adsorption of proteins to the outer particle surface. The characteristics 
of PEG will be discussed in depth in chapter 4. 
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2.5 COLLECTION OF USED SILICA NANOPARTICLES 
 
Table 2.4: Characterization of silica nanoparticles used in this thesis. Size was determined via dynamic light 
scattering. ζ potentials were determined via electrophoretic light scattering. Nanoparticle names are composed of 
the particle size, surface modification (P=PEG, D=DIAMO) and the fluorescence dye (RITC or PI). 
Name Design Surface 
modification 
Fluorescence 
labelling 
Size in 
HBSS (nm) 
ζ 
potential 
(mV) 
N25-RITC  
 
 
- RITC 25.4 ± 2.51 -22.9 
N25-D-RITC  
 
 
DIAMO RITC 795.9 ± 5.3 +21.8 
N30-RITC  
 
 
- RITC 29.8 ± 0.18 -32.0 
N37-RITC  
 
 
- RITC 37.2 ± 3.70 -35.0 
N45-RITC  
 
 
- RITC 45.3 ± 0.16 -29.0 
N50-RITC  
 
 
- RITC 49.7 ± 0.06 -42.7 
N50-P-RITC  
 
 
PEG RITC 54.6 ± 0.86 -27.5 
N62-RITC  
 
 
- RITC 61.6 ± 0.07 -31.4 
N77-RITC  
 
 
- RITC 77.2 ± 0.53 -28.0 
N77-RITC  
 
 
PEG RITC 87.2 ± 2.42 -25.0 
N94-RITC  
 
 
- RITC 93.7 ± 4.19 -37.6 
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N94-P-RITC  
 
 
PEG RITC 97.4 ± 3.03 -35.4 
N21-PI  
 
 
- PI 21.1 ± 0.48 -33 mV 
N34-PI  
 
 
- PI 34.0 ± 1.40 -0.17* 
N61-PI  
 
 
- PI 61.4 ± 0.54 -12.1* 
N74-PI  
 
 
- PI 73.8 ± 2.40 -0.48* 
N84-PI  
 
 
- PI 84.0 ± 0.21 -5.55* 
 
* The surface modification with the fluorescence dye PI caused interactions with the measurement principle for 
determination of the ζ potential.  
  
3 
Oxidative and cytotoxic potential of 
fluorescently-labelled silica nanoparticles 
 
 
Parts of this chapter have been submitted for publication as journal articles: 
1. A. Neumeyer, C.-M. Lehr & N. Daum. Novel method for the non-invasive determination of 
reactive oxygen species in vitro. Submitted to Toxicology In Vitro 
 
2. A. Neumeyer, M. Bukowski, M. Veith, C.-M. Lehr & N. Daum. Non-invasive determination 
of the cytotoxic effect caused by fluorescently-labelled silica nanoparticles. In preparation 
 
 
Nanomaterials are innovative tools in the field of drug delivery. Thereby, inorganic 
nanoparticles such as silica particles provide promising characteristics as novel drug carriers. 
Since silica exposure has also been associated with the generation of reactive oxygen species, 
it is essential for a thorough risk assessment to analyze the cytotoxic and oxidative potential 
of nanoparticles. Recent opinions of the Scientific Committee on Consumer Products (SCCP) 
of the European Commission and the European Food Safety Authority (EFSA) underlined this 
approach, suggesting the validation of in vitro methodologies for nanomaterials. Furthermore, 
nanoparticles often interfere with various standardized assays revealing again the importance 
for the development of alternatives for already commercially available techniques. Therefore, 
a novel method for the combined detection of oxidative stress and cytotoxicity was
established. This assay is based on the automated non-invasive online monitoring of the 
oxygen concentration in solution (SensorDish® Reader). Silica nanoparticles with different 
sizes and surface modifications were investigated with this novel method concerning their 
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oxidative and cytotoxic potential. Thereby, size, time, concentration as well as surface 
modification of nanoparticles affected cellular viability but not oxidative stress levels.  
 
 
 
3.1 INTRODUCTION 
 
Silica nanoparticles have to be investigated concerning their oxidative and cytotoxic potential, 
particularly with regard to a pharmaceutical or medical application where particles come in 
close contact with biological systems. Recent studies described that silica nanoparticles can 
cause oxidative stress (Eom & Choi, 2009; Park & Park, 2009; Wang et al., 2009) which is in 
turn associated with deleterious effects resulting in several serious diseases such as 
autoimmune diseases and cancer (Avalos et al., 2007; Gonsette, 2008; Rice-Evans & Burdon, 
1993; Sayre et al., 2008). These findings reveal that the validation of the oxidative and 
cytotoxic potential of nanomaterials is of great interest. To exclude potential harmful effects, 
these new materials have to undergo a thorough risk assessment. Referring to this, the 
European Food Safety Authority (EFSA) and the Scientific Committee on Consumer Products 
(SCCP) of the European Commission recently published opinions on the safety of 
nanomaterials in cosmetic products or food (EFSA, 2009; SCCP, 2007). It is suggested that 
nanomaterials should be treated as new chemicals from a risk point of view. For this purpose, 
various in vitro assays already exist. However, the use of standardized assays for the detection 
of oxidative stress and cytotoxicity with these new kinds of materials pose specific 
challenges. Because of their material properties, nanomaterials often cause interactions with 
many standardized assays revealing the importance for the development of useful alternatives 
for already commercially available techniques (Laaksonen et al., 2007; Ulukaya et al., 2008; 
Wahl et al., 2008; Worle-Knirsch et al., 2006).  
 
Oxidative stress arises with an imbalance of the generation and the decomposition of reactive 
oxygen species (ROS). Normally, cells are able to defend themselves against ROS damage, 
using their antioxidant defence mechanism which includes enzymes such as superoxide 
dismutases (SOD) and catalases (Johnson & Giulivi, 2005; Lavrovsky et al., 2000; Sies, 
1993). However, after exposure to oxidants the ROS levels can increase dramatically which 
results in damages affecting all types of biological molecules including lipids, proteins, 
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carbohydrates and nucleic acids. This can lead to protein oxidation and fragmentation, lipid 
peroxidation, membrane damage, mutagenesis and carcinogenesis (Sies, 1986).  
 
ROS are either free radicals, reactive anions containing oxygen atoms or molecules containing 
oxygen atoms. They can produce free radicals or are chemically activated by themselves, e.g., 
the hydroxyl radical (OH•), superoxide anion radical (O2•-) and hydrogen peroxide (H2O2) all 
result from molecular oxygen (O2) (Figure 3.1). In vivo the main amount of ROS is generated 
in mitochondria during the aerobic respiration (Fernandez-Checa et al., 1998). In addition to 
this endogenous oxidative stress, exogenous factors including UV- or X-rays, ozone, smog 
and the exposure to chemicals such as nicotine are much more hazardous and result in an 
increased generation of ROS (Baier et al., 2007; Barr et al., 2007; Bertram & Hass, 2008; 
Rugo & Schiestl, 2004; Wang et al., 2006). A well known method for the detection of 
oxidative stress is the 2’, 7’-dichlorofluorescein diacetate (DCF-DA) assay (Rosenkranz et al., 
1992; Wang & Joseph, 1999). This method is based on a fluorescence assay first described by 
Keston and Brandt (Brandt & Keston, 1965) who employed DCF-DA to measure hydrogen 
peroxide in aqueous solution.  
 
Figure 3.1: Summary of the antioxidant defence mechanism. Superoxide anion (O2-) is scavenged by the 
antioxidant superoxide dismutase (SOD). Glutathione peroxidase (GP) uses hydrogen peroxide (H2O2) to convert 
reduced glutathione (GSH) to oxidized glutathione (GSSG). Glutathione reductase (GR) reduces GSSG to GSH 
via nicotinamide adenine dinucleotide phosphate (NADPH) oxidation, while catalase decomposed H2O2 into 
water and molecular oxygen (Maier & Chan, 2002). 
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Oxidative stress can result in cytotoxicity, wherefore the cytotoxic potential of nanoparticles 
have to be investigated as well. Assays for the detection of cytotoxicity address many cellular 
parameters as cytotoxicity can occur in nearly all parts of the cell and in every cell organelle. 
Exposure to cytotoxic molecules can result in a loss of membrane integrity, cell lysis and 
necrosis. In consequence of these damages, cell growth and division are arrested, which can 
be detected as a decrease in cellular viability. Furthermore, apoptosis can be activated, which 
is characterized by well defined events including shrinkage of the cytoplasm and nuclear 
condensation. Cytotoxicity assays detect either the damage of cell membranes (mechanical 
cytotoxicity) or the mitochondrial metabolism (metabolic cytotoxicity). One common 
measured parameter in cell death and cell lysis determination is lactate dehydrogenase (LDH) 
which is released from the cytosol of damaged cells into the supernatant. For the measurement 
of cellular proliferation and viability, MTT assay is a well known example. All these assays 
are easy to perform but they detect only high-specific alterations of one cellular or metabolic 
parameter at one selected time point and they are mostly invasive methods (Fotakis & 
Timbrell, 2006; Weyermann et al., 2005).  
 
As an alternative to standardized and commonly-used assays such as DCF-DA, LDH or MTT, 
a novel assay using the SensorDish® Reader (SDR) was established. This method allows an 
automated and combined online detection of ROS generation and cytotoxicity in vitro. This 
method was so far applied for the monitoring of cell cultivation, bacterial respiration and the 
validation of cytotoxicity caused by several drugs (Beckers et al., 2009; Kensy et al., 2005; 
Noor et al., 2009). The measurement principle is based on the automated online monitoring of 
the molecular oxygen concentration in a microtiter plate format (Kocincova et al., 2008). 
Cellular respiration is associated with a consumption of oxygen and therefore serves as an 
indicator for cytotoxicity. Cytotoxicity can be determined measuring the long-term cellular 
consumption of oxygen during cell incubation. An increase in air saturation caused by 
decreased cellular consumption of oxygen is a very early indication for cytotoxicity before 
other toxicity markers such as mitochondrial dysfunction or destruction of the cell membrane 
can be detected. The generation of ROS as an indication for oxidative stress was determined 
indirectly measuring the conversion of oxygen radicals via superoxide dismutase. 
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3.2 AIM OF THE STUDY 
 
Aim of this study was to evaluate an alternative to standardized assays for the detection of 
cytotoxicity and oxidative stress in vitro. For this purpose the SensorDish® Reader (SDR) was 
used. In this study, a first-time combined non-invasive method for the detection of ROS and 
cytotoxicity in vitro based on the cellular consumption of molecular oxygen was established. 
Therefore, the SDR assay had to be adjusted for the detection of ROS in cellular systems, as 
the method had never been used before for this application. For this establishment H2O2 
served as a model substance for the generation of ROS causing oxidative stress. The 
involvement of the SOD during exposure to H2O2 was investigated as well. Furthermore, the 
novel assay was evaluated by comparison with well known standardized assays for the 
detection of ROS (DCF-DA) and cytotoxicity (LDH and MTT).  
 
This new established assay allows the evaluation of the oxidative and cytotoxic potential of 
different silica nanoparticles with various sizes and surface modifications.  
 
 
 
3.3  MATERIALS AND METHODS 
 
3.3.1 Materials 
Dulbecco’s modified eagle medium with high glucose (4.5 g/l) and L-glutamine was obtained 
from Gibco (Karlsruhe, Germany), fetal bovine serum was purchased from PAN-Biotech 
(Aidenbach, Germany), non-essential amino acids were obtained from PAA (Cölbe, 
Germany). 2’, 7’-dichlorofluorescein diacetate (97%), 2’, 7’-dichlorofluorescein (~90%), 
sodium diethyldithiocarbamate trihydrate, hydrogen peroxide (30%), thiazolyl blue 
tetrazolium bromide, bovine serum albumin and polyethylenimine (PEI) (25 kDa) were 
purchased from Sigma (Munich, Germany). Composition of Hank’s balanced salt solution 
was as follows: 136.9 mM NaCl, 5.4 mM KCl, 4.26 mM NaHCO3, 0.35 mM KH2PO4, 
5.5 mM glucose, 10 mM HEPES, 1.26 mM CaCl2, 0.5 mM MgCl2*6H2O, 0.4 mM 
MgSO4*7H2O. Hank’s balanced salt solution was adjusted to pH 7.4 by means of NaOH. 
Cytotoxicity detection kit for lactate dehydrogenase was purchased from Roche Applied 
Science (Mannheim, Germany), OxoDish® plates were obtained from PreSens (PreSens 
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Precision Sensing GmbH, Regensburg, Germany). BreathSeal® foils were obtained from 
Greiner bio-one (Essen, Germany). 
 
 
3.3.2 Caco-2 cell culture 
The human colon adenocarcinoma cell line, Caco-2, clone C2Bbe1, was purchased from 
American Tissue Culture Collection (ATCC, Manassas, VA) and used at passages 60-80. 
Cells were cultured in Dulbecco’s modified eagle medium (DMEM) with high glucose 
(4.5 g/l) and L-glutamine, supplemented with 10% fetal calf serum (FCS) and 1% non-
essential amino acids and were maintained under standard culture conditions at a temperature 
of 37°C and in a humidified atmosphere of 5% CO2. The culture medium was changed three 
times a week. For oxygen measurements with the SensorDish® Reader (SDR), Caco-2 cells 
were cultured in 24-well OxoDish® plates at a density of 1x105 cells per well in 1 ml culture 
medium and were allowed to attach and proliferate for 96 hours. For the determination of the 
conversion of DCF-DA into DCF (DCF-DA assay), Caco-2 cells were plated into 96-well 
plates at a density of 2x104 cells per well in 0.2 ml culture medium and allowed to attach and 
proliferate for 96 hours as well. For MTT assay Caco-2 cells were cultured also in 96-well 
plates in a density of 2x104 cells per well and were cultivated for 8 days.  
 
 
3.3.3 SensorDish® Reader (SDR) 
The SensorDish® Reader (SDR) is an innovative system for the measurement of the molecular 
oxygen concentration (O2) in solution. For this purpose special 24-well plates (OxoDish® 
plates) were used. These sterile multidishes contain sensor spots on the bottom of each well, 
which consist of an oxygen-sensitive fluorescent dye embedded in a tissue compatible 
polymer (Figure 3.2). The fluorescence lifetime of this dye depends on the amount of oxygen 
in solution. The emitted sensor signal is read out non-invasively through the bottom of the 
OxoDish® plates by the SDR and is converted automatically to e.g., oxygen air saturation (%) 
or oxygen concentration (mg/L) using calibration parameters provided in the corresponding 
software (SDR_V37). A decrease in air saturation refers to an increase in oxygen 
consumption which is indicative for viable cells, whereas an increase in air saturation 
indicates a loss of cellular activity. The calculated alteration in air saturation results from the 
difference between the value for air saturation under normal culture conditions (buffer 
control) and the value of the top of an amplitude which develops e.g., after application of 
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H2O2. Measurements can be performed in user-defined time intervals. To avoid evaporation 
effects in the 24-well plates, all dishes were sealed with an air- and gas-permeable foil 
(BreathSeal® foils).  
         
A                                                                                                                   B 
Figure 3.2: Assembling of the SensorDish® Reader (SDR). (A) SDR with an OxoDish® plate on top. Sensor 
spots are immobilised at the bottom of each well. (B) Measurement principle of the SDR. The sensor is excited 
by the reader non-invasively through the transparent bottom of the OxoDish® plates. Its emission is detected 
from the bottom side as well. Images were received from PreSens (Regensburg, Germany).  
 
For the detection of oxidative stress, Caco-2 cells were cultured for 96 hours in 
OxoDish® plates. Alterations in air saturation were documented every hour during cell 
cultivation. After the cell culture medium was removed, H2O2 in different concentrations 
(75, 150, 300, 1000 and 2000 µM) diluted in DMEM was added to the cells. To analyse the 
involvement of the SOD in the course of the assay establishment, cells were pre-incubated for 
24 hours with the SOD inhibitor diethyldithiocarbamate trihydrate (DDC). This hydrophobic 
chelating agent removes Cu (II) ions from the active site and thus inactivating the SOD 
(Fridovich, 1986; Khazaei et al., 2009). Cells were treated with different concentrations 
(20, 100 and 200 µM) of DDC before 2000 µM H2O2 were applied as described before. 
MTT experiments demonstrated no cytotoxic effect of the used DDC concentrations (data not 
shown). For the evaluation of the oxidative potential of nanoparticles, cells had been 
additionally washed with HBSS, whereupon various nanoparticles in different concentrations 
(10, 50, 100, 200 and 500 µg/ml) were added to the cells. H2O2 in a concentration of 1000 µM 
served as a positive control. After addition of the test substance measurements were 
performed every minute for 1 hour.  
 
For detection of cytotoxicity, Caco-2 cells were treated as described in the paragraph above. 
Triton-X (0.000001-1%), polyethylenimine (PEI) (0.01-100 µg/ml) or different nanoparticles 
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in different concentrations (10-500 µg/ml) (dispersed in HBSS) were added to the cells. The 
consumption of molecular oxygen, indicative for the cell growth behaviour, was detected over 
24 hours every hour. Triton-X served as a positive control for cytotoxicity. To investigate, if 
the cytotoxic effects are reversible, Caco-2 cells were cultured for 48 hours as described 
before. Afterwards cells were treated for 4, 8 and 24 hours with nanoparticles dispersed in 
HBSS or with HBSS alone. After these incubation times (4, 8 and 24 hours), cells were rinsed 
with HBSS and were cultured in DMEM for further 72 hours.  
 
To exclude the detection of chemical reactions due to H2O2 or nanoparticles, all experiments 
were additionally performed in a cell-free milieu as well. Therefore, OxoDish® plates were 
incubated with DMEM under standard cell culture conditions in the absence of cells. 
Afterwards H2O2 or nanoparticles were added as described before.  
 
 
3.3.4 DCF-DA assay 
The production of intracellular ROS was measured using 2’, 7’-dichlorofluorescein diacetate 
(DCF-DA). DCF-DA is a non-ionic, non-polar and non-fluorescent fluorescein derivative 
which is able to cross cell membranes and is hydrolyzed enzymatically by intracellular 
esterases. In the presence of ROS DCF-DA is oxidized to the highly fluorescent 
dichlorofluorescein (DCF). A 10 mM DCF-DA stock solution (in dimethyl sulfoxide, DMSO) 
was diluted in Hank’s balanced salt solution (HBSS) with 1% bovine serum albumin (BSA) to 
obtain a working solution with a concentration of 20 µM. Final DMSO concentration was 
kept below 0.2%. After cell cultivation, Caco-2 cells were washed twice with HBSS 
supplemented with 1% BSA, followed by an incubation of DCF-DA at 37°C for 30 minutes. 
After that period DCF-DA was removed and H2O2 in different concentrations (75-1000 µM) 
or nanoparticle dispersions (10-500 µg/ml) were added and incubated at 37°C for 
180 minutes. This time point had been determined in previous time kinetic experiments, 
where an increase in fluorescence over time had been shown (data not shown). HBSS with 
1% BSA served as negative control. To investigate the suitability of different buffers and 
media, the above described experiment was performed with HBSS, DMEM and DMEM 
without phenol red, respectively. Emission of the developed fluorescence was analyzed with a 
fluorescence plate reader (Infinite M200, Tecan, Crailsheim, Germany) using a 
485 nm extinction filter and a 530 nm emission filter. Measurements were performed 
immediately after addition of H2O2 or after a 180-minute-incubation. 
3          Oxidative and cytotoxic potential of silica nanoparticles 35 
 
 
3.3.5 LDH assay 
The release of lactate dehydrogenase (LDH) from damaged cells was detected in a two-step 
enzymatic reaction. In the first step LDH catalyzes the conversion of lactate to pyruvate, 
which results in the reduction of NAD+ to NADH/H+. In a second step the catalyst transfers 
H/H+ from NADH/H+ to the tetrazolium salt INT which is reduced to a water-soluble 
formazan dye. The absorbance of this formazan dye was measured at an absorbance of 
492 nm (Infinite M200, Tecan, Crailsheim, Germany). Caco-2 cells were treated with 
different concentrations of triton-X (0.000001%-1%) or different nanoparticles (N50-RITC 
and N50-P-RITC) in different concentrations (100-500 µg/ml). The release of LDH into the 
supernatant was analyzed after 2, 4, 6 and 8 hours. An interference of the used nanoparticles 
with the LDH assay was excluded performing substance control tests beforehand (data not 
shown).  
 
 
3.3.6 MTT assay 
Cells were treated with N50-RITC and N50-P-RITC particles in a concentration of 200 µg/ml 
in HBSS and were incubated for 4, 8 or 24 hours. The MTT reagent was subsequently added 
for further 4 hours. Cytotoxicity was determined by measuring the reduction of the yellow 
tetrazolium salt thiazolyl blue tetrazolium bromide (MTT) to water-insoluble purple formazan 
crystals by metabolic active cells. Formazan crystals were extracted with DMSO and their 
absorbance was measured at 550 nm (Infinite M200, Tecan, Crailsheim, Germany). An 
interference of the used nanoparticles with the MTT assay was excluded performing 
substance control tests beforehand (data not shown).  
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3.4 RESULTS 
 
3.4.1 Establishment of a method for the combined determination of oxidative stress 
and cytotoxicity via SDR measurements 
 
3.4.1.1 Determination of oxidative stress via SDR 
3.4.1.1.1 Cell concentration- and H2O2 concentration-dependent increase in molecular 
oxygen
 
The SDR had previously been used for the monitoring of cell cultivation and the non-invasive 
determination of cytotoxicity based on cellular O2 consumption. For its application in the 
detection of oxidative stress in human cell culture systems, a new assay had to be established. 
For this purpose, H2O2 served as a model substance to generate ROS resulting in oxidative 
stress in Caco-2 cells. After cells were cultivated for 96 hours under standard cell culture 
conditions, H2O2 in different concentrations, (75-2000 µM) diluted in cell culture medium 
(DMEM), was added to the cells. Measurements of the resulting oxygen concentration were 
performed directly after addition of H2O2. Figure 3.3 A shows exemplarily a typical SDR run 
of control cells (treated with DMEM alone) (black circles) and cells treated with 
1000 µM H2O2 (open circles). Immediately after the addition of H2O2 (Figure 3.3 A, arrow) a 
strong increase in air saturation (+55.50% ± 0.54) and consequently in the concentration of 
molecular oxygen was documented. This effect reached a maximum after 1 hour, followed by 
a short stagnation with a subsequent decrease of molecular O2. Control cells also showed a 
low increase in air saturation (+6.35% ± 0.93) due to variations in temperature. Within about 
six hours, control cells reached nearly their basic value (-3.77% ± 0.80), whereas cells which 
were incubated with 1000 µM H2O2 exhibited a great difference between the amount of air 
saturation before application of H2O2 and after the reaction (+14.34% ± 2.11) (Figure 3.3 A). 
This observed effect was associated with the amount of cells as can been shown in 
Figure 3.3 B. H2O2 in a concentration of 1000 µM was added to Caco-2 cells, which were 
cultured for 48, 72 or 96 hours. Cells which were cultured for 48 or 72 hours exhibited a 
reduced reaction to H2O2 when compared to cells cultivated for 96 hours. The air saturation 
was increased by +23.28% ± 2.53 for Caco-2 cells cultured for 48 hours and by 
+33.67% ± 2.7 for cells cultured for 72 hours (Figure 3.3 B). 
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Figure 3.3: Influence of H2O2 on Caco-2 cells. (A) Run of an SDR experiment to measure indirectly the 
generation of oxygen radicals in Caco-2 cells cultivated for 96 hours under standard cell culture conditions. 
Measurements were performed every minute after application of DMEM as control or H2O2 (arrow). For 
clarification not all time points were plotted. Data represent the mean ± SD of three wells. (B) Cell 
concentration-dependent increase in air saturation after application of H2O2. Caco-2 cells were cultivated for 48, 
72 and 96 hours under standard cell culture conditions. Afterwards 1000 µM H2O2 was added to the cells. 
Plotted data were calculated by subtracting the starting air saturation from the maximal occurred air saturation. 
Data represent the mean ± SD of three wells. The asterisks depict significant differences between different cell 
cultivation times (p≤0.01**, p≤0.001***). 
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The results of three independent experiments with different concentrations of H2O2 (75-
2000 µM) are presented in Figure 3.4 A, where a concentration-dependent increase of oxygen 
concentration could be detected. H2O2 in a concentration of 75 µM did not increase the air 
saturation compared to the DMEM control, while 2000 µM H2O2 resulted in a highly 
significant increase (p≤0.00058). The used concentrations of H2O2 and the resulting increase 
in air saturation exhibited a very strong correlation with a coefficient of determination of 
0.9636 (Figure 3.4 B).  
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Figure 3.4: Increase in air saturation due to the application of H2O2. (A) H2O2 in different concentrations (75-
2000 µM) was added to Caco-2 cells cultured for 96 hours. Plotted data were calculated by subtracting the 
starting air saturation from the maximal occurred air saturation. Data represent the mean ± SD of three 
independent experiments. The asterisks depict significant differences between the control and H2O2 treated cells 
(p≤0.05 *, p≤0.001 ***). (B) Correlation between H2O2 concentration and the increase in air saturation. Data 
represent the mean ± SD of three independent experiments. 
 
As the degradation product of H2O2 is O2 as well, it was necessary to investigate the 
behaviour of H2O2 in a milieu without any cells to exclude a chemical effect only. Directly 
after the addition of H2O2, this cell-free experiment showed a decrease in air saturation 
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(Figure 3.5, black bars). The rising of the oxygen concentration during the experiment was 
similar to that of control cells treated with DMEM alone (Figure 3.5, grey bars). These results 
confirmed a cellular and therefore biological answer to H2O2 and excluded a chemical 
reaction.  
 
Figure 3.5: SDR experiments in absence of cells. OxoDish® plates were incubated with DMEM under normal 
cell culture conditions but in absence of cells. H2O2 in different concentrations (150-1000 µM) was added to the 
DMEM medium. The direct effect (black bars) as well as the maximum effect during H2O2 exposure (grey bars) 
were determined. Data represent the mean ± SD of three independent experiments. 
 
 
3.4.1.1.2 Involvement of the SOD in the H2O2-induced effect 
The observed H2O2-induced effect of Caco-2 cells was supposed to be caused by the SOD. To 
prove the involvement of the SOD, an enzyme of the antioxidant defence mechanism, Caco-2 
cells were pre-incubated with DMEM or the specific SOD-inhibitor DDC (20-200 µM) for 
24 hours. After this pre-incubation cells were treated with 2000 µM H2O2. Samples which 
were not pre-incubated with DDC showed a strong increase in molecular oxygen 
(+125.99% ± 7.81) as could be detected already in previous experiments. The pre-incubation 
with 20 µM DDC caused a reduction in air saturation of 73.57% compared to control cells 
incubated with DMEM without DDC. DDC in a concentration of 100 µM exhibited a further 
reduction of the H2O2 induced effect (+2.57% ± 0.42) or even resulted in a decrease of air 
saturation when using 200 µM DDC (-15.98% ± 0.33) (Figure 3.6) which is an indication for 
a complete inhibition of the SOD. Previous MTT experiments demonstrated no cytotoxic 
effect of the used DDC concentrations (data not shown). 
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Figure 3.6: Influence of DDC on the H2O2-induced effect. Caco-2 cells were cultured for 96 hours. Cells were 
pre-incubated for 24 hours with DDC in different concentrations (20-200 µM) followed by the addition of 
2000 µM H2O2. Bars show the alteration in air saturation after H2O2 application by subtracting the starting air 
saturation from the maximal occurred air saturation. Data represent the mean ± SD of three independent 
experiments. The asterisks depict significant differences between control and DDC treated cells (p≤0.01 **). 
 
 
3.4.1.1.3 Comparison with the DCF-DA assay 
The authenticity of experiments with this novel technique was confirmed with a conventional 
fluoriometric assay for the detection of oxidative stress using 2’, 7’-dichlorofluorescein 
diacetate (DCF-DA). Furthermore, the comparability of the SDR assay with a standardized 
method should be clarified. Caco-2 cells were pre-incubated with DCF-DA followed by a 
three-hour-incubation with different concentrations of H2O2 diluted in DMEM or 
HBSS with 1% BSA. The resulting emission values, based on the conversion of DCF-DA into 
the fluorescent dichlorofluorescein (DCF), were documented every hour over a 3-hour-
incubation (data not shown). The occurred fluorescence is a parameter for the presence of 
ROS. The usage of the standard cell culture medium (DMEM) was not possible, because the 
medium interfered with the fluorescent measuring system. DMEM without addition of phenol 
red caused problems with the measurements technique as well (Figure 3.7 A). Thereupon, 
DCF-DA experiments were performed in HBSS supplemented with 1% BSA. Similar to the 
results of the SDR measurements, H2O2 caused a concentration-dependent increase in the 
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conversion of DCF-DA after three hours indicative for the generation of ROS (Figure 3.7 B). 
Thereby, the DCF-DA assay had a lower detection limit than the SDR assay. 
 
A  
B  
Figure 3.7: Standard DCF-DA assay for the detection of oxidative stress. (A) Fluorescence measurements of 
converted DCF-DA in HBSS, HBSS supplemented with 1% BSA, DMEM and DMEM without phenol red 
(DMEM*) after addition of H2O2 in different concentrations (0, 300 and 1000 µM). (B) Caco-2 cells were 
cultured for 96 hours and were pre-incubated with DCF-DA in HBSS+1% BSA for 30 minutes. Afterwards H2O2 
in different concentrations (75-1000 µM) was added to Caco-2 cells followed by a 3-hour-incubation. Data 
represent the mean ± SD of three independent experiments. The asterisks depict significant differences between 
the control and H2O2 treated cells (p≤0.001 ***). 
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Measurements were also performed directly after addition of H2O2 without a 3-hour-
incubation step. No difference between several H2O2 concentrations and the HBSS + 1% BSA 
control could be observed (data not shown) which indicates that the conversion of DCF-DA 
into DCF seems not to be an immediate process and requires a longer incubation time. 
 
 
3.4.1.2 Determination of cytotoxicity via SDR 
To prove the correlation between the amount of cells and the consumption of molecular 
oxygen, Caco-2 cells were seeded with different cell numbers (6 300 – 78 900 cells per cm2) 
in OxoDish® plates. The variation of the air saturation was measured every 30 minutes over 
16 hours. Measurements were started with a delay of 1 hour, because the system needs about 
1 hour to equilibrate (temperature and pH) after seeding the cells. Already 2 hours after 
seeding the cells a concentration-dependent decrease in air saturation was visible (Figure 3.8). 
The SDR run clarified that there is a strong correlation between the amount of seeded cells 
and the consumption of oxygen. A high cell concentration (79 000 cells per cm2) showed a 
decrease in air saturation of 12.92% ± 4.16 over 16 hours, whereas lower concentrated cells 
(6 300 cells per cm2) caused a reduction in air saturation of 5.11% ± 0.56. Cell-free samples 
showed no variation in air saturation during the whole experiment.  
 
 
Figure 3.8: Alteration in air saturation correlates with the cell number. Air saturation profiles of several seeding 
densities of Caco-2 cells. Cells were seeded in different concentrations in OxoDish® plates and were cultured for 
16 hours under normal cell culture conditions. Measurements were performed every 30 minutes. Data represent 
the mean ± SD of three wells. 
3          Oxidative and cytotoxic potential of silica nanoparticles 44 
 
 
The cytotoxic potential of an added reagent is reflected by the decrease in cellular 
consumption of O2. For this purpose, triton-X served as a model substance causing 
cytotoxicity due to permeabilization of the cell membranes. Therefore, Caco-2 cells were 
treated with different concentrations of triton-X (0.000001%-1%) solved in DMEM. Samples  
incubated with the highest triton-X concentration (1%) showed a clear increase in air 
saturation directly after addition of triton-X. Air saturation values of samples with lower 
triton-X concentrations (0.0001%-0.1%) showed a concentration-dependent approximation to 
the highest triton-X concentration. However, control cells, cultivated in DMEM during the 
whole experiment, caused a decrease in air saturation over time which suggests a high 
consumption of molecular oxygen by viable cells (Figure 3.9 A). These results were proved 
with a standardized assay detecting the LDH release from damaged cells which is a 
commonly used and standardized marker for cell membrane integrity and cytotoxicity. 
Supernatants of all samples were collected simultaneously to the SDR measurements and 
analyzed concerning their LDH leakage over 8 hours. No clear concentration-dependent 
release of LDH could be detected for triton-X during the experiment. For the lower triton-X 
concentrations (0.000001%-0.01%) no increased LDH release could be detected when 
compared to the medium control, while the treatment with 0.1% and 1% triton-X showed 
already after two hours a very strong LDH release (Figure 3.9 B). In contrast to the SDR 
assay, where a clear concentration-dependent effect could be observed, the LDH assay 
exhibited either no or the maximal cytotoxic effect without any intermediate steps.  
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Figure 3.9: Air saturation correlates with occurred cytotoxicity. (A) Determination of triton-X-induced 
cytotoxicity via SDR measurements. Increase in air saturation due to the application of triton-X over time. Cells 
were incubated with different concentrations of triton-X solved in DMEM for 4, 8, 16 and 20 hours, respectively. 
(B) Determination of the triton-X-induced effect via LDH assay. Caco-2 cells were incubated with different 
concentrations of triton-X solved in DMEM. Supernatants were collected and analyzed concerning LDH leakage 
after 2, 4, 6 and 8 hours. Measurements were performed with an absorbance plate reader. Data represent the 
mean ± SD of three independent experiments. 
 
After finishing these establishment experiments, this novel assay could apply for the 
determination of oxidative stress and cytotoxicity in particulate systems such as silica 
nanoparticles.  
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3.4.3 Oxidative and cytotoxic potential of silica nanoparticles  
 
3.4.3.1 Determination of the oxidative potential of silica nanoparticles via SDR in comparison 
to DCF-DA measurements 
For determination of nanoparticulate-induced ROS generation, Caco-2 cells were plated for 
96 hours in OxoDish® plates. Nanoparticles (N50-RITC, N50-P-RITC, N94-RITC and N94-P-
RITC) were diluted in HBSS in different concentrations (10, 100, 200 and 500 µg/ml) and 
were added to the cells. H2O2 in a concentration of 1000 µM served again as a positive control 
for generation of ROS. Measurements were performed every minute after addition of 
nanoparticles. H2O2 with a concentration of 1000 µM  showed a high increase in air saturation 
of 32.16% ± 5.83 compared to the buffer control, while nanoparticles caused no significant 
increase in air saturation (Figure 3.10 A). This result could be also confirmed with a DCF-
DA assay. Caco-2 cells plated in a 96-well plate were incubated with DCF-DA for 
30 minutes, followed by addition of nanoparticles for further 180 minutes. H2O2 caused a 
conversion of DCF-DA into DCF of 3.05% ± 0.77, whereas all tested nanoparticles showed 
no increased DCF-DA conversion compared to the buffer control (0.93% ± 0.06) 
(Figure 3.10 B).  
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Figure 3.10: Determination of the oxidative potential of nanoparticles via SDR and DCF-DA measurements. 
(A) Detection of ROS generation via alteration in air saturation by SDR measurements. Different nanoparticles 
(N50-RITC, N50-P-RITC, N94-RITC and N94-P-RITC) in different concentrations (10-500 µg/ml) were added 
to Caco-2 cells plated in OxoDish® plates. H2O2 served as a positive control. (B) Detection of ROS generation 
via conversion of DCF-DA into DCF. Caco-2 cells were pre-incubated with DCF-DA for 30 minutes. 
Afterwards, different nanoparticles (N50-RITC, N50-P-RITC, N94-RITC and N94-P-RITC) in different 
concentrations (10-500 µg/ml) were added to the cells followed by a 3-hour-incubation. The buffer control 
(HBSS or HBSS + 1% BSA) is displayed by the dashed line. Data represent the mean ± SD of three independent 
experiments.
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3.4.3.2 Size-, time-, surface modification- and concentration-dependent nanoparticulate 
cytotoxicity 
Long-term determination of nanoparticulate cytotoxicity was measured on the basis of the 
consumption of oxygen over 24 hours. Caco-2 cells were plated for 96 hours in OxoDish® 
plates. For the cytotoxic evaluation of a particulate model substance, Caco-2 cells were 
incubated with PEI in different concentrations (0.01-100 µg/ml). PEI polymers are widely 
used as a transfection reagent in non-viral gene delivery. Used PEI polymers had a size of 
12.02 nm ± 0.56 when dispersed in HBSS in a concentration of 100 µg/ml. After addition of 
PEI, cells showed a time- and concentration-dependent decrease in oxygen consumption 
indicative for a cytotoxic effect of PEI. Concentrations up to 1 µg/ml caused no inhibition in 
cellular activity when compared to the buffer control. In contrast, cells treated with PEI in a 
concentration of 10 and 100 µg/ml exhibited a clear time- and concentration-dependent 
cytotoxic effect similar to that of the triton-X control (Figure 3.11). 
 
 
Figure 3.11: Cytotoxic potential of polyethylenimine (PEI) as a particulate model substance analysed via SDR. 
PEI in different concentrations (0.01-100 µg/ml) was added to Caco-2 cells cultivated for 96 hours. 
Measurements were performed every hour over 24 hours. Bars exhibit the additional consumption of O2 related 
to the HBSS control after 4, 8, 12, 16, 20 and 24 hours. Data represent the mean ± SD of three independent 
experiments.  
 
For the cytotoxic evaluation of silica nanoparticles, various nanoparticles (N50-RITC, N50-P-
RITC, N94-RITC and N94-P-RITC) were dispersed in HBSS in different concentrations 
(10, 100, 200 and 500 µg/ml) and were added to the cells. Triton-X in a concentration of 
0.01% served as positive control for cytotoxicity. Measurements were performed every hour. 
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Already after 4 hours, a clear difference between the tested nanoparticles was visible. N50-
RITC nanoparticles caused a clear increase in air saturation and consequently a reduced 
consumption of oxygen. Particularly, at higher concentrations (200-500 µg/ml) N50-
RITC particles provoked a strong effect by adjusting to the air saturation values of the triton-
X control indicative for cell death. After a 16-hour-incubation, N50 –RITC particles in a 
concentration of 500 µg/ml caused a lower cellular oxygen consumption as the one 
documented for triton-X at this time point (Figure 3.12 A). N94-RITC particles as well as 
PEG-modified nanoparticles (N50-P-RITC and N94-P-RITC) showed no alteration in air 
saturation during the experiment when compared to the buffer control (HBSS) (Figure 3.12 B-
D) and therefore did not generate cytotoxicity in Caco-2 cells. For N50-P-RITC and N94-P-
RITC particles a minor cytotoxic effect could be detected after 24 hours.  
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Figure 3.12: Determination of the cytotoxic potential of different RITC-labelled silica nanoparticles via SDR 
measurements. Nanoparticles
 
in different concentrations (100-500 µg/ml) were added to Caco-2 cells. 
Measurements were performed every hour over 24 hours. (A) N50-RITC, unmodified nanoparticles, 50 nm, 
(B) N50-P-RITC, PEG-modified nanoparticles, 55 nm, (C) N94-RITC, unmodified nanoparticles, 94 nm, 
(D) N94-P-RITC, PEG-modified nanoparticles, 97 nm. Bars exhibit the additional consumption of O2 related to 
the HBSS control after 4, 8, 12, 16, 20 and 24 hours. Data represent the mean ± SD of three independent 
experiments. 
 
To evidence the observed cytotoxicity, the LDH release after incubation with N50-RITC and 
N50-P-RITC particles in different concentrations (100-500 µg/ml) during the first 8 hours of 
the experiment were analysed simultaneously to the SDR measurements. A clear 
concentration- and time-dependent release of LDH could be detected for N50-RITC particles, 
whereas N50-P-RITC particles showed no increased LDH release compared to the HBSS 
control (Figure 3.13). 
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Figure 3.13: Determination of the cytotoxicity of silica nanoparticles via LDH assay. Caco-2 cells were 
incubated with N50-RITC and N50-P-RITC nanoparticles. Supernatants were collected and analyzed concerning 
LDH leakage after 2, 4, 6 and 8 hours. Data represent the mean ± SD of three independent experiments. 
 
In addition, an MTT assay was performed to evaluate the metabolic viability of the cells after 
incubation with nanoparticles. This assay was not able to detect the cytotoxic effects of N50-
RITC nanoparticles which could be determined via LDH and SDR. Nanoparticles caused a 
decrease in metabolic viability over 24 hours but when compared to the HBSS control they all 
showed increased absorbance values indicative for an enhanced metabolic activity of the cells 
after nanoparticle incubation (data not shown). 
 
Furthermore, to exclude a cytotoxic effect of the fluorescent dye RITC or other ingredients of 
the nanoparticle solution, Caco-2 cells were treated with free RITC and the supernatant of 
nanoparticle dispersions as well. No alteration in cellular viability could be demonstrated for 
these samples when compared to the buffer control. (data not shown).  
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3.4.3.3 PI-labelled nanoparticles caused a size-, time-, concentration-dependent and non-
reversible cytotoxic effect in Caco-2 cells  
As described before, Caco-2 cells were plated for 96 hours in OxoDish® plates. PI-labelled 
nanoparticles (N21-PI, N34-PI and N84-PI) were diluted in HBSS in different concentrations 
(20, 100, and 500 µg/ml) and were added to the cells. Again, triton-X in a concentration of 
0.01% served as a positive control for cytotoxicity. Measurements were performed every hour 
over 24 hours. Caco-2 cells incubated with different sized nanoparticles in a concentration of 
20 µg/ml exhibited no increase in air saturation when compared to the HBSS control. In 
contrast, nanoparticles in a concentration of 100 µg/ml and 500 µg/ml caused a clear size- and 
time-dependent cytotoxic effect. N84-PI nanoparticles in a concentration of 20 and 100 µg/ml 
had no influence on cellular viability at all. In a concentration of 500 µg/ml these particles 
already showed a very strong cytotoxic effect after an incubation of 8 hours (Figure 3.14 C). 
N34-PI nanoparticles in a concentration of 100 µg/ml demonstrated a clear effect after a 16-
hour-incubation (Figure 3.14, B). Similar results could be also detected for N21-PI 
nanoparticles. They already caused cytotoxicity after a 8-hour-incubation (Figure 3.14, A) 
when applied in a concentration of 100 µg/ml. Higher concentrated (500 µg/ml) N34-PI and 
N21-PI nanoparticles exhibited a cytotoxic effect already after an incubation time of 4 hours.  
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A  
B  
C  
Figure 3.14: Determination of the cytotoxic potential of unmodified PI-labelled silica nanoparticles via SDR 
measurements. N21-PI, N34-PI and N84-PI nanoparticles
 
in different concentrations (20, 100 and 500 µg/ml) 
were added to Caco-2 cells. Measurements were performed every hour over 24 hours. (A) N21-PI, (B) N34-PI, 
(C) N84-PI. Bars exhibit the additional consumption of O2 related to the HBSS control after 4, 8, 12, 16, 20 and 
24 hours. Data represent the mean ± SD of three independent experiments. 
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3.4.3.4 Nanoparticle-damaged Caco-2 cells do not regenerate 
To investigate, if the observed cytotoxic effect of nanoparticles is reversible, Caco-2 cells 
were cultivated for 48 hours, subsequently cells were incubated with N34-PI or N84-PI 
nanoparticles for 4, 8 and 24 hours. As a control, cells were cultured in HBSS alone for 4, 8 
and 24 hours. Figure 3.15 A shows exemplarily the SDR run of N34-PI treated cells with the 
corresponding HBSS controls, in comparison to cells cultured in DMEM (negative control) or 
in 0.01% triton-X (positive control). HBSS caused only a rather low decrease in cellular 
viability when compared to the DMEM control. In contrast, nanoparticle-treated cells 
exhibited a high increase in air saturation when compared to the DMEM control indicative for 
a decrease in cellular viability. After a 72-hour-incubation in DMEM, HBSS treated cells 
demonstrated still a consumption of oxygen indicative for metabolically active cells. In 
contrast, nanoparticle-incubated cells exhibited a size- and time-dependent decrease in oxygen 
consumption based on a cytotoxic effect of these nanoparticles. The nanoparticle induced 
cytotoxicity was not reversible within 72 hours (Figure 3.15 B).  
 
As described before for RITC-labelled nanoparticles, a cytotoxic effect of the fluorescent dye 
PI or other ingredients of the nanoparticle solutions was excluded by treating cells with free 
PI or the supernatant of nanoparticle dispersions. No alteration in cellular viability could be 
demonstrated for these samples when compared to the buffer control. (data not shown).  
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Figure 3.15: Reversibility of the nanoparticle induced cytotoxic effect. N34-PI and N84-PI nanoparticles in a 
concentration of 100µg/ml were added to Caco-2 cells and were incubated for 4, 8 and 24 hours. After this 
incubation time, cells were washed with HBSS and were cultivated in DMEM for further 72 hours under 
standard cell culture conditions. (A) SDR run of Caco-2 cells cultivated with N34-PI particles or HBSS for 4, 8 
and 24 hours. Arrows mark the time point, when nanoparticle incubation was finished and Caco-2 cells were 
cultivated in DMEM again. Data represent the mean ± SD of three wells. (B) Increase in air saturation related to 
the DMEM control after a 72-hour-incubation in DMEM. Triton-X in a concentration of 0.01% served as a 
positive control for cytotoxicity. Data represent the mean ± SD of three independent experiments. 
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3.5 DISCUSSION 
 
Silica nanoparticles have various advantages and characteristics which are promising tools in 
the medical and pharmaceutical field, but they are also known to cause cell damage such as 
oxidative stress or inhibition of cellular respiration (Eom & Choi, 2009; Park & Park, 2009; 
Tao et al., 2008; Wang et al., 2009). Recent publications reported the application of silica 
nanoparticles as drug and gene carrier (Bharali et al., 2005; Gemeinhart et al., 2005; Manzano 
et al., 2009; Simovic et al., 2010; Tan et al., 2010), which underline the importance to provide 
a safe method for the oxidative and cytotoxic evaluation of nanoparticles. Oxidative stress and 
cytotoxicity are two parameters which have to be analyzed, especially as these materials come 
into close contact with biological barriers, e.g., the gastrointestinal epithelium when 
administered via the oral route. 
 
In case of oxidative stress, free radicals are the molecules of action. They seem to have a 
pathologic role in a variety of diseases such as atherosclerosis and cancer (Rice-Evans & 
Burdon, 1993; Trush & Kensler, 1991). Free radicals are produced permanently as natural 
metabolism products sustaining essential functions. By the time there is an imbalance of the 
generation and the decomposition of ROS, these molecules can impair cells. Typical sources 
of damaging ROS are e.g. ultraviolet rays as well as X- and ionising radiation. However, also 
pharmaceuticals such as diazepam or clofibrate (Bogdanska et al., 2007; Qu et al., 2001) and 
innovative drug delivery tools like nanoparticles can cause uncontrolled production of free 
radicals. Many different nanoparticles were already reported to induce oxidative stress in 
different cell lines. Cerium oxide nanoparticles caused an increase in ROS, which triggered 
the activation of cytosolic caspase-3 and a chromatin activation which led on the other hand to 
cytotoxicity via an apoptotic process (Park et al., 2008). Such an increase in ROS with a 
simultaneous decrease in glutathione could be also observed in human embryonic kidney cells 
after incubation with amorphous SiO2 nanoparticles (Wang et al., 2009). In addition to the 
formation of ROS, silica nanoparticles have also been shown to induce heme-oxygenase-1, 
another antioxidative enzyme (Eom & Choi, 2009). A comparative study demonstrated that 
metallic nanoparticles caused oxidative stress eight times higher if compared to aqueous 
solutions of the same metals (Limbach et al., 2007). These findings suggest for an in-depth 
examination of these new materials with regard to the production of ROS.  
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For the detection of ROS in vitro various commercially available assays already exist using 
different markers for oxidative stress such as superoxide dismutase, glutathione or catalase. A 
well-established standard assay for the determination of ROS is the DCF-DA assay 
(Rosenkranz et al., 1992), a fluorescent based method which detects ROS generation by 
determining the conversion of DCF-DA into DCF. However, the assay exhibits several 
disadvantages as its long incubation time of at about 1 hour and particularly that it is an 
invasive and end-point assay. Furthermore, this assay shows various interactions with assay 
media or buffers. Grzelak et al. already demonstrated via DCF-DA assay a very high 
generation of ROS in many standard cell culture media such as DMEM or RPMI even without 
any addition of ROS-inducing substances (Grzelak et al., 2000; Grzelak et al., 2001). Similar 
results were obtained in a DCF-DA experiment with Caco-2 cells. In this study, it could be 
shown that pH indicators such as phenol red could cause interactions with the measurement 
principle. This common medium supplement resulted in a very high background fluorescence 
which interacted with the measuring wavelength of DCF. In contrast, experiments with 
DMEM without any addition of phenol red caused another difficulty. In these samples no 
difference in DCF-DA conversion between single H2O2 concentrations was visible. Because 
of its high complexity, cross reactions with various ingredients could not be excluded. 
Therefore, it was necessary to use special buffers coming along with an alteration in standard 
culture or experimental conditions. This again may result in stressed cells and consequently in 
an interference with experimental results. However, physiological buffers, such as HBSS, 
without any protein addition showed already in the negative control a very high conversion of 
DCF-DA into DCF causing a high background. The lack of proteins resulted in metabolically 
stressed cells. These experiments clarified the high limitation in the choice of buffers or 
media. Consequently, the DCF-DA assay is very sensitive to different cell culture buffers or 
media due to various interferences. Furthermore, new materials such as nanoparticles often 
show interactions with the measurement principles itself. This could already be demonstrated 
for standardized assays for the detection of cytotoxicity (Wahl et al., 2008; Worle-Knirsch et 
al., 2006). Therefore, it is recommended to evidence data of these techniques with at least two 
or more independent test systems (Worle-Knirsch et al., 2006). Opinions of different 
European institutions support this proposal (EFSA, 2009; SCCP, 2007). 
 
These findings clarify the high demand for the establishment of alternatives to already 
available assays. Therefore, in the present study a non-invasive assay for the combined 
detection of ROS and cytotoxicity using the SDR was established. Thereby, the intestinal 
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adenocarcinoma cell line Caco-2 served as an in vitro model with regard to the development 
of oral nanoparticulate drug delivery systems. The innovative method is based on a 
fluorescent measuring principle detecting specifically solved molecular oxygen (O2) in the 
samples (Beckers et al., 2009; Kensy et al., 2005). During the establishment for the detection 
of oxidative stress, H2O2 served as model substance for the generation of ROS in vitro. H2O2 
can diffuse freely in and out of cells and tissue. Its ability to cross biological membranes 
allows targeting a wide range of intracellular and extracellular structures. In vitro, H2O2 
oxidizes cellular ferrous iron into ferric iron, hydroxyl radical and hydroxyl anion via Fenton 
reaction by the following molecular equation: Fe2+ + H2O2  Fe3+ + OH• + OH-. This 
reaction is a main source of oxidative stress in the cell based on the generation of hydroxyl 
radical (OH•). OH• can react with further cellular molecules, whereby the development of 
further ROS such as superoxide anion radical (O2•-) or again H2O2 is possible. As the H2O2 
induced increase in air saturation could be inhibited via addition of an SOD inhibitor (DDC), 
the strong rise of oxygen generation during SDR measurements after addition of H2O2 is 
related to the activation of the SOD. Therefore, O2•- seemed to be involved in the occurred 
cellular answer to H2O2 and its cellular consequences. The SOD is the first enzyme of the 
antioxidant defence mechanism and converts produced O2•- in the following reaction: 2O2•-
 + 2H+ + SOD  H2O2 + O2 (Maier & Chan, 2002; Marklund, 1980). Thereupon, resulting 
H2O2 is degraded to molecular oxygen and water by the enzyme catalase: 
2 H2O2  2 H2O + O2 (Sies, 1986). This reaction explains the increase in oxygen air 
saturation after H2O2 exposure. Different studies already described the association between 
H2O2 application and the increase in SOD activity (Bose Girigoswami et al., 2005; 
Drazkiewicz et al., 2003; Nagy et al., 1995). The reaction of the SOD is extremely fast, 
having a turnover of 2x109M-1sec-1 (Malstrom et al., 1975). This fast reaction becomes 
apparent by the rapid increase in air saturation after the addition of H2O2. However, further 
experiments would be necessary to proof the role of catalase in this reaction. 
 
As no alteration in air saturation could be detected in a cell free milieu, a chemical interaction 
with medium ingredients or the oxygen sensor caused by H2O2 or its decomposition products 
could be excluded. The H2O2-induced effect is completely absent due to the fact that 
antioxidative enzymes are not present and therefore not able to eliminate produced ROS. The 
cell concentration-dependent reaction to H2O2 is a further indication for a biological process. 
An increased amount of cells is associated with an increased O2 detection after addition of 
H2O2.  
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Besides oxidative stress, also cytotoxicity is an indispensable parameter which should be 
evaluated in vitro. Cytotoxicity can be a result of oxidative stress, as ROS can affect cell 
membranes and other molecules such as nucleic acids. For this reason cytotoxic effects are 
often accompanied with oxidative stress. Cellular response to silver (Ag) nanoparticles 
demonstrated a decrease in mitochondrial function with an increase in membrane leakage of 
LDH. Simultaneously, a significant depletion of the glutathione level and an increase of ROS 
levels could be detected. These findings hypothesized that cytotoxicity of Ag nanoparticles is 
likely mediated through oxidative stress (Hussain et al., 2005). In this context, the SDR 
allows the determination of cytotoxicity in vitro as well. The cytotoxic potential of a test 
substance or material can be determined by monitoring the cellular consumption of oxygen 
over time. Thereby, oxygen consumption is directly associated to the metabolic activity of 
cells. Consequently, the oxygen concentration in solution was decreased in the 
presence of viable cells due to the cellular consumption of oxygen. In contrast, stressed or 
dying cells caused an increase or a stagnation in O2 concentration (Beckers et al., 2009). The 
cellular consumption of oxygen is a very sensitive and early state marker for detection of 
cytotoxicity. Events such as mitochondrial dysfunction, mitochondrial permeability transition 
and apoptosis come along with a decrease in cell respiration, which is directly related to 
cellular viability (Deshpande et al., 2004).  
 
Triton-X permeabilizes cell membranes and served as a cytotoxic model reagent. Using 
different concentrations of triton-X (0.000001% to 1%) a clear concentration dependent 
increase in air saturation could be observed when compared to the medium control (DMEM) 
via SDR measurements. The SDR assay was able to detect small differences in the O2 
consumption of different triton-X concentrations in the standard cell culture medium. The 
SDR assay detected a cytotoxic potential for 0.01% triton-X in DMEM and HBSS. Thereby, 
the reduced cytotoxic effect in DMEM medium is based on the general improved growth 
conditions in a complex cell culture medium compared to a physiological buffer without 
further supplements such as proteins or amino acids. A comparative LDH assay showed no 
differences in LDH release between 0.000001% and 0.01% triton-X as well as the medium 
control. Just 0.1% and 1% triton-X caused a detectable LDH leakage. This experiment was 
performed in the standard cell culture medium containing phenol red which led to interactions 
with the LDH assay (very high background absorbance). In contrast, 0.01% triton-X diluted in 
HBSS showed a clear leakage of LDH compared to the HBSS control which demonstrated 
again the limitation in the choice of the media. Finally, the novel technique exhibited various 
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advantages over the standardized LDH assay. The SDR assay could be performed in 
physiological buffers as well as in highly complexed cell culture media. Furthermore, the 
sensitivity of the SDR assay allowed the determination of the concentration-dependent 
cytotoxicity of triton-X diluted in DMEM which was not possible via LDH. As a further 
control, Caco-2 cells were treated with PEI, which is a particulate substance that can mimic 
the cytotoxic effect of nanoparticles. Its already known cytotoxicity is based on its very strong 
absorption to the cell membrane. This results in a polymer layer on the cell surface which 
causes a perforation of cell membranes and a plasma membrane dysfunction leading to cell 
death via necrosis (Daum et al., 2009; Fischer et al., 1999).  
 
The SDR assay allows an online sample analysis at different time points during the 
experiment. Standardized assays for the detection of cytotoxicity are all end-point and mostly 
invasive assays. Furthermore, the measurement principle of these assays often shows 
interaction with test materials, especially with nanomaterials. First of all, the MTT assay is 
known to cause a lot of interactions with nanoparticles due to their material properties 
(Laaksonen et al., 2007; Ulukaya et al., 2008; Worle-Knirsch et al., 2006). Single-walled 
carbon nanotubes appeared to interact with the formazan salt of MTT. This interference does 
not affect the enzymatic reaction but it stabilizes the chemical structure of the produced 
formazan salts and prevents them from being solubilized (Worle-Knirsch et al., 2006). Also 
porous silica microparticles exhibited interactions with the MTT assay, through which MTT 
was reduced in a spontaneous redox reaction. These findings demonstrate that there are 
various interactions of nanoparticles with assay reagents which do therefore not allow the use 
of standardized methods. In contrast to all these conventional assays the SDR showed no 
interference with fluorescently-labelled nanoparticles. Furthermore, the measurement 
principle of the SDR caused no interaction with media containing supplements such as phenol 
red and therefore analysis could be performed in buffer as well as in complex cell culture 
media.  
 
Aim of the described evaluation was to apply this novel method for the combined 
determination of the oxidative and cytotoxic potential of silica nanoparticles. Therefore, silica 
nanoparticles with different sizes (21-94 nm) and with different surface modifications 
(unmodified and PEG-modified) were investigated with the SDR assay concerning their 
oxidative and cytotoxic capability. For the determination of the oxidative potential, these 
nanoparticles were analyzed via SDR and were compared in a DCF-DA assay. Particles in all 
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concentrations showed no increased air saturation independent of their surface modification. 
These results could be confirmed by the DCF-DA assay, where nanoparticles did not cause an 
increased conversion of DCF-DA into DCF, whereas H2O2 demonstrated a high rate of 
converted DCF after 3 hours. Thus, the tested silica nanoparticles did not generate ROS in 
Caco-2 cells. An increased generation of HO• was already described for crystalline silica 
nanoparticles. It was suggested, that Fenton reactions occurred on the particles surface which 
results in an increased ROS production. However, also amorphous silica nanoparticles were 
reported to cause oxidative stress in different cell systems such as human bronchial epithelial 
cells, macrophages and embryonic kidney cells (Eom & Choi, 2009; Park & Park, 2009; 
Wang et al., 2009). As amorphous silica nanoparticles used in this study caused no generation 
of ROS, it is suggested that the mentioned cell systems are more sensitive against oxidative 
stress than Caco-2 cells. Furthermore, the shape, size, composition and incubation time of 
nanoparticles play an essential role in these investigations. 
 
Despite the missing oxidative effect, used silica particles showed strong differences in 
cytotoxicity. In contrast to particles with a size of 94 nm (N94-RITC) and PEG-modified 
nanoparticles (N50-P-RITC and N94-P-RITC), smaller particles with sizes between 21 and 
84 nm (N50-RITC, N21-PI, N34-PI and N84-PI) exhibited a clear size-, concentration- and 
time-dependent cytotoxic reaction compared to the buffer control. These evidences suggested 
that N94-RITC particles and PEG-modified particles did not affect the cells in their viability. 
In contrast, all other particles showed a very strong reduction in the consumption of oxygen 
indicative for a decrease in cellular activity. This occurred cytotoxic effect could be also 
confirmed by an LDH assay, where N50-RITC or N50-P-RITC particles were added to the 
cells. Again, N50-RITC particles demonstrated a high LDH leakage over 8 hours comparable 
with the triton-X control. PEG-modified nanoparticles (N50-P-RITC) did not affect the cells 
and caused no increased LDH release when compared to the HBSS control. Comparison of 
the data with an MTT assay demonstrated that the evaluation of cytotoxicity via oxygen 
consumption is much more sensitive than the determination via these standard assays, because 
it was not possible to detect the cytotoxic potential of the used nanoparticles via MTT assay. 
Long-term toxicity studies demonstrated that the occurred cytotoxic effect of N34-PI and 
N84-PI nanoparticles was not reversible. Caco-2 cells which were incubated for 4, 8 or 
24 hours exhibited still after an incubation in DMEM for further 72 hours a decreased oxygen 
consumption if compared to the HBSS controls. Apparently, nanoparticles caused invasive 
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cellular damages, so that cells could not regenerate in such a short recovery phase. Which cell 
structures were affected by nanoparticles, should be investigated in further experiments.  
 
Hitherto, the molecular mechanism of nanoparticulate induced cytotoxicity is not fully 
understood and has to be investigated more detailed. It is assumed that cytotoxicity is caused 
by cellular injuries through a variety of mechanism such as membrane peroxidation, 
glutathione depletion, mitochondrial dysfunction and DNA damage (Tao et al., 2009). As it 
has been reported that nanoparticles were able to enter the cell nucleus as well, it is of 
particular importance, that also genotoxicity should become a stronger research field. Silver 
nanoparticles up-regulated DNA damage repair proteins and induced cell death. Furthermore, 
these genotoxic effects were again strong associated with the cellular uptake rate and 
intracellular localization of these particles (Ahamed et al., 2008). DNA damage was also 
caused by carbon nanotubes which were able to penetrate into the cell nucleus through 
nucleopores and caused a destruction of DNA strands (Pantarotto et al., 2004). Silica 
nanoparticles were described to enter the nucleus and thus influenced the gene expression of 
the cells as well (Chen & Mikecz von, 2005). Most likely, the size-, time-, concentration- and 
also surface modification-dependent cytotoxic effect, which could be observed in this study is 
based on the internalization of nanoparticles into the cell. It had been already suggested that 
acute cytotoxicity is primarily originated from the cellular internalization of nanoparticles 
rather than from physical damage of the cell membrane (Yang et al., 2009). 
 
The observed cytotoxicity correlates with the results of conducted cell association and uptake 
studies (compare to chapter 4 and 5) showing that smaller particles had a very strong 
association with Caco-2 cells or even were taken up into the cells. N94-RITC particles as well 
as PEG-modified nanoparticles, which did not alter the cell growth behaviour, showed no 
association with Caco-2 cells. The absence of a cytotoxic effect of PEG-modified 
nanoparticles can be explained via the characteristics of PEG. A surface modification of 
nanoparticles with PEG caused a reduction in the adhesion of opsonin proteins in the blood 
serum in vivo, which resulted in a higher biologic resistance and stability of such modified 
nanoparticles (Peracchia et al., 1999; Peracchia et al., 1999). In vitro, a similar mechanism 
could play a role in the decreased cellular association of PEG-modified nanoparticles. 
Proteins, which are involved in the docking of particles to the outer cell surface, could not 
adhere to particles modified with PEG. As a result, nanoparticles, which are not able to come 
into close contact with cells, do not influence cellular viability.  
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3.6 CONCLUSION 
 
The SDR represents a sensitive, rapid, convenient and first of all a non-invasive method for 
the simultaneous detection of ROS generation and cytotoxicity in cell culture systems. 
Furthermore, it allows long-term measurements and online documentation of the cell 
behaviour. Another advantage of this method is that no additional reagents are required. This 
is very important when evaluating the oxidative or cytotoxic effect of nanoparticles, because 
they often show interactions with these assay reagents. Furthermore, its very short assay 
duration permits the evaluation of a great number of samples in a reasonable time and 
therefore can be used in high throughput screenings. In conclusion, the SDR represents a 
potential alternative to well-known standard assays for the detection of oxidative stress and 
cytotoxicity. So far, no non-invasive assay for the long-term evaluation of oxidative stress or 
cytotoxicity exists, which make the SDR to a highly innovative and promising method in this 
research field.  
 
Used silica nanoparticles caused no generation of ROS in Caco-2 cells but exhibited a size-, 
time-, concentration- and surface modification-dependent cytotoxic effect. These findings 
were closely associated with conducted cell association and uptake studies (compare to 
chapter 4 and 5). Nanoparticles which were associated with cells or were even taken up into 
cells caused cytotoxicity as well. Therefore, it was supposed, that the cellular internalization 
of nanoparticles influences the cell viability.  
 4 
Cellular binding, association and transport of 
rhodamine B-isothiocyanate-labelled silica 
nanoparticles 
 
 
Parts of this chapter have been submitted for publication as a journal article: 
A. Neumeyer, M. Bukowski, M. Veith, C.-M. Lehr & N. Daum. PI-labelling of nanoparticles 
as novel tool for the quantification of cellular binding and uptake. Submitted to 
Nanomedicine: Nanotechnology, Biology and Medicine 
 
 
Silica nanoparticles are promising tools in the field of oral drug delivery. The main obstacle 
of this application route is the overcoming of the intestinal barrier and the insistence against 
cells of the immune system. In the present study rhodamine B-isothiocyanate (RITC)-labelled 
silica nanoparticles with different sizes (25-94 nm) and surface modifications (+/- poly 
ethylene glycol, PEG) were investigated concerning their cellular association and uptake 
properties in Caco-2 cells. In flow cytometry studies a clear size-and time-dependent cell 
association could be detected for unmodified RITC-labelled nanoparticles with a size of 
50 and 77 nm, whereas large particles (94 nm) and PEG-modified nanoparticles showed no 
interaction with Caco-2 cells. These findings were also confirmed via confocal microscopy. 
Different cell preparation protocols gave further information about the cellular localization of 
these particles. Conducted transport experiments correlated with the association studies. Small 
and unmodified nanoparticles showed the highest transport across Caoc-2 monolayers, 
whereas PEG-modified nanoparticles were not or rather low transported.  
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4.1 INTRODUCTION 
 
Oral delivery is the most attractive route for drug application due to the high patient 
compliance. However, oral bioavailability of new macromolecular drug candidates such as 
peptides or oligonucleotides is very low because administered drugs have to overcome several 
biological obstacles. Besides degradation by pancreatic and gastric enzymes, primarily they 
have to resist the high acidity of the stomach. Furthermore, the intestinal epithelial barrier 
exhibits a metabolic as well as a physical barrier and thus prevents the uptake of 
microorganisms and other particles (Hamman et al., 2005; Mustata & Dinh, 2006; Soltero & 
Ekwuribe, 2005). The intestinal epithelium consists of a cell monolayer mostly composed of 
enterocytes which build a tight interface. Molecules which are absorbed in the intestine can be 
delivered to the hepatic portal vein and finally enter the systemic circulation (Soltero & 
Ekwuribe, 2005). In this study, the enterocyte-like Caco-2 cell line served as an in vitro model 
of the small intestine. These cells form a polarized monolayer with an apical brush border 
morphologically comparable to that of the human colon (Hidalgo et al., 1989; Hilgers et al., 
1990). In addition to the overcoming of biological barriers, the opsonization and clearance by 
macrophages is another major obstacle in drug delivery which reduces oral bioavailability 
remarkably (Gref et al., 2003; Gref et al., 1994; Owens & Peppas, 2006). 
 
An overcoming or circumvention of these barriers would lead to an enhancement in the oral 
bioavailability of new drug candidates such as peptides, proteins, plasmids, antibodies and 
nucleic acids. One delivery strategy could be based on the encapsulation into or adsorption of 
drugs and molecules to nanoparticles. Nanoparticle surface modification with 
poly ethylene glycol (PEG) extend the residence time of nanoparticles in the blood. The effect 
of PEG is based on the defilade of nanoparticles over surface chemistry, hence avoiding the 
phagocytic system (Owens & Peppas, 2006). PEG conjugation can reduce reticuloendothelial 
clearance, the uptake by macrophages, the recognition by the immune system and the 
degradation by proteolytic enzymes (Roberts et al., 2002). Furthermore, PEG shows 
stabilizing properties on the nanoparticle surface due to a steric barrier formed by the PEG 
chains (Behrens et al., 2002; Tobio et al., 2000).  
 
Hitherto, various studies demonstrate an uptake of silica nanoparticles in cells or nuclei (Chen 
& Mikecz von, 2005; Peng et al., 2006; Vallhov et al., 2007) using confocal microscopy 
(CLSM) as a qualitative visualization technique. However, there is a lack of studies 
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quantifying the amount of particles associated with cells. The quantification of 
nanoparticulate uptake is very important, especially when different materials or studies should 
be compared.  
 
  
 
4.2 AIM OF THE STUDY 
 
The aim of this study was to evaluate the cellular association of rhodamine B-isothiocyanate 
(RITC)-labelled silica nanoparticles with different sizes and surface modifications in a 
quantitative way using flow cytometry. As flow cytometry measurements can not distinguish 
between adsorbed and internalized nanoparticles, different buffers were tested to remove 
particles from the outer cell membranes.  
 
Furthermore, the transport properties of RITC-labelled silica nanoparticles across Caco-2 
monolayers were investigated.  
 
 
 
4.3 MATERIALS AND METHODS 
 
4.3.1 Materials 
Dulbecco’s modified eagle medium (DMEM) with high glucose (4.5 g/l) and L-glutamine 
was obtained from Gibco (Karlsruhe, Germany), fetal bovine serum was purchased from 
PAN-Biotech (Aidenbach, Germany), non-essential amino acids were obtained from PAA 
(Cölbe, Germany). Composition of Hank’s balanced salt solution (HBSS) was as follows: 
136.9 mM NaCl, 5.4 mM KCl, 4.26 mM NaHCO3, 0.34 mM Na2HPO4*7H2O, 
0.35 mM KH2PO4, 5.5 mM glucose, 10 mM HEPES, 1.26 mM CaCl2, 0.5 mM MgCl2*6H2O, 
and 0.4 mM MgSO4*7H2O. HBSS was adjusted to pH 7.4 by means of NaOH. Phosphate 
buffered saline (PBS) was as follows: 129 mM NaCl, 2.5 mM KCl, 7 mM Na2HPO4*7H2O 
and 1.3 mM KH2PO4. PBS was adjusted to pH 7.4 by means of NaOH, as well. The pH 5 
buffer was as follows: 28 mM C2H3NaO2, 117 mM NaCl and 2 mM EGTA. The pH 5 buffer 
was adjusted to pH 5 by means of HCl. Citric acid, tween 20 and bovine serum albumin were 
obtained from Sigma (Munich, Germany). FITC-labelled wheat germ agglutinin (WGA) was 
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purchased from Vector Laboratories (Burlingame, CA). Culture slides were obtained from BD 
Falcon (Franklin Lakes, NJ).  
 
 
4.3.2 Caco-2 cell culture 
The human colon adenocarcinoma cell line, Caco-2, clone C2Bbe1, was purchased from 
American Tissue Culture Collection (ATCC, Manassas, VA) and used at passages 60-80. 
Cells were cultured in Dulbecco’s modified eagle medium (DMEM) with high glucose 
(4.5 g/l) and L-glutamine, supplemented with 10% fetal calf serum (FCS) and 1% non-
essential amino acids and were maintained under standard culture conditions at a temperature 
of 37°C and in a humidified atmosphere of 5% CO2. The culture medium was changed three 
times a week. For flow cytometry studies, Caco-2 cells were cultured in 6-well plates at a 
seeding density of 5x105 cells per well in 2 ml culture medium and were allowed to attach and 
proliferate for 48 hours. For confocal laser scanning microscopy (CLSM) experiments, Caco-
2 cells were plated on 4 chamber glass culture slides at a seeding density of 1x105 cell per 
well in 1 ml medium and allowed to attach and proliferate for 8 to 10 days until reaching a 
confluence of 60-70%. 
 
 
4.3.3 Visualization of cellular association by confocal laser scanning microscopy 
(CLSM) 
Caco-2 cells (1x105 per well) were cultured on 4 chamber glass culture slides for 8 to 10 days 
under standard cell culture conditions. Afterwards, adherent cells were incubated with RITC-
labelled nanoparticles (N50-RITC, N50-P-RITC, N77-RITC, N77-P-RITC, N94-RITC and 
N94-P-RITC) for 4 hours under standard cell culture conditions. After incubation with these 
nanoparticles, cell membranes were stained with FITC-labelled wheat germ agglutinin 
(WGA) and cells were fixed with 4% formalin in PBS. If required, nuclei were stained with 
4’,6-diamidino-2-phenylindole (DAPI). After the staining procedure fixed cells were imaged 
via CLSM using LSM510 (Zeiss, Jena, Germany). The used objective was a water immersion 
objective 63x. Measurements were performed with Zeiss LSM510 Software.  
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4.3.4 Quantification of cellular or nuclear association by flow cytometry (FACS) 
Quantification of the cellular or nuclear association of RITC-labelled nanoparticles was 
investigated via flow cytometry using a FACSCalibur (Beckon Dickinson, Heidelberg, 
Germany). Data were analysed with the BD CellQuest Pro software and FlowJo flow 
cytometry analysis software. Control cells or nuclei which were not incubated with 
nanoparticles emitted always a weak background fluorescence (Figure 4.1 A, grey peak). In 
contrast, cells which were associated with fluorescently-labelled nanoparticles showed a shift 
to higher fluorescence intensities (Figure 4.1 A, black line). Emitted light resulting from 
RITC-labelled nanoparticles was detected by the FL2 detector. The measurement of the green 
fluorescence (e.g. FITC wavelength) served as a negative control because used cells should 
exhibit no alteration in the emission of this wavelength. To calculate the background 
fluorescence of unlabelled cells, cells without any addition of nanoparticles (HBSS treated 
cells) were carried along as a buffer control in every measurement. Quantitative analysis was 
performed by means of quadrant statistics placing a quadrant marker which divides a 2D plot 
into four quadrants. Thus, the percentage of cells in each quadrant could be calculated. The 
unlabelled cell population was placed in the lower left quadrant of the dot plot and exhibited 
cells without associated nanoparticles. In contrast, nanoparticle associated and therefore 
fluorescently-labelled cells were placed in the lower right quadrant (Figure 4.1 B-D).  
   
 
Figure 4.1: Analysis of the quantification of the cellular association of nanoparticles. (A) Histogram of Caco-2 
cells incubated in HBSS (grey peak) and associated with RITC-labelled nanoparticles (black line). (B) Division 
of a 2D dot plot in quadrants. Unlabelled cells were placed in the lower left quadrant. Cells which were 
associated with RITC-labelled nanoparticles were located in the lower right quadrant. (C) Dot plot inclusive 
quadrant statistics of unlabelled Caco-2 cells and (D) cells associated with RITC-labelled nanoparticles.  
A B 
C D 
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4.3.5 Cell preparation protocols 
Caco-2 cells in a concentration of 5x105 per well were plated in 6-well plates and cultured for 
48 hours under standard cell culture conditions. Afterwards, adherent cells were incubated for 
different times (1, 2, 4 or 8 hours) under standard cell culture conditions with unmodified 
(N50-RITC, N77-RITC, N94-RITC) or PEG-modified silica nanoparticles (N50-P-RITC, 
N77-P-RITC and N94-P-RITC). For the following flow cytometry analysis, cells were 
prepared in three different ways: (i) whole cell preparation, (ii) nucleus preparation and 
(iii) nucleus isolation. For whole cell and nuclei preparation analysis 10 000 cells or nuclei 
were counted, for nuclei isolation analysis 5 000 nuclei were counted. Size was determined 
via the forward scatter (FSC) and granularity was determined via the sideward scatter (SSC). 
 
(i) Whole cell preparation 
Caco-2 cells were harvested with trypsin and washed three times with PBS. Whole cells 
exhibited a very low granularity due to an intact cell membrane (Figure 4.2 A).  
 
(ii) Nucleus preparation 
Cells were harvested with trypsin as well, washed with PBS and fixed in 70% ethanol for 
24 hours. After this procedure fixed cells were incubated with a triton-X containing 
permeability buffer (PBS + 0.5% triton-X) and washed again with PBS supplemented with 
1% BSA. Prepared nuclei were still associated with cytoplasm, various cell organelles and 
parts of the permeabilized cell membrane which resulted in a high granularity (Figure 4.2 B).  
 
(iii) Nucleus isolation 
Adherent cells were incubated with a citric acid/tween20 buffer (H2O + 2.1% citric acid and 
0.5% tween20). Nuclei were collected and were fixed in 70% ethanol for 24 hours. After this 
fixation nuclei were washed several times in PBS containing 1% tween20 and were collected 
finally in PBS. A dot plot of these isolated nuclei showed small structures with a very low 
granularity (Figure 4.2 C).  
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Figure 4.2: Cell or nucleus preparation and nucleus isolation. (A) Analysis of whole Caco-2 cells. Cells were 
trypsinized and washed three times with PBS. (B) Analysis of prepared cell nuclei. Cells were trypsinized, fixed 
in ethanol for 24 hours and permeabilized with a triton-X containing buffer. (C) Analysis of isolated nuclei. 
Adherent cells were incubated in a citric acid/tween20 buffer, nuclei were collected, fixed in ethanol for 24 hours 
and washed several times with PBS containing tween 20. Dot plots are the result of 10 000 measured cells or 
prepared nuclei or 5 000 isolated nuclei, respectively. Analysed cell populations are marked with a gate. 
 
 
4.3.6 Cell washing procedures 
Caco-2 cells in a concentration of 5x105 per well were plated in 6-well plates and were 
cultured for 48 hours as described before. Afterwards, adherent cells were incubated for 
1 minute with N25-RITC nanoparticles. This short incubation time excluded a real uptake into 
the cell. Afterwards cells were washed with different buffers for several times (Table 4.1). 
Whole cells were analysed via flow cytometry as described in chapter 4.3.4.  
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Table 4.1: Washing buffers to remove nanoparticles from the outer cell surface. 
Buffer Ingredients Concentrations 
pH 5 buffer Sodium acetate 
Sodium chloride 
EGTA 
28 mM 
117 mM 
2 mM 
Trypsin 50 Trypsin 
PBS 
50% 
Trypsin 10 Trypsin  
PBS 
10% 
Triton-X 0.0001 Triton-X 
PBS 
0.0001% 
Triton-X 0.001 Triton-X 
PBS 
0.001% 
Pronase 0.5 Pronase 
PBS 
0.5 mg/ml 
Pronase 1 Pronase 
PBS 
1 mg/ml 
 
 
4.3.7 Transport studies 
Caco-2 cells in a concentration of 6x104 per well were plated in 12-well Transwell® plates 
using polycarbonate membranes with a pore size of 0.4 µm. The assembling of such a 
Transwell system is presented in figure 4.3. Cells were cultured on these membranes for 21 -
28 days under standard cell culture conditions. During this cultivation, the development of the 
transepithelial electrical resistance (TEER) was determined at regular intervals to ensure 
membrane integrity of the monolayers. The TEER was measured via chopstick electrodes 
connected to an epithelial voltohmmeter (EVOM, World Precision Instruments, Sarasota, FL). 
The long-term development of the TEER of a Caco-2 cell monolayer was determined with the 
CellZscope® (nanoAnalytics, Münster, Germany) as well. The CellZscope® is an instrument 
measuring the transepithelial impedance of cell layers under physiological conditions. It is 
computer-controlled and allows automated and a long-term monitoring of cell cultures.  
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Before starting the experiment, Caco-2 cell monolayers were pre-incubated with the transport 
buffer (HBSS) for 30 minutes. Transport of nanoparticles was investigated in absorptive 
direction (apical to basolateral compartment). During the experiments, Transwell® plates were 
agitated using an orbital shaker at 150 rpm. Samples were taken after 4, 8 and 24 hours from 
the receiver compartment. After each sample collection, an equal volume of fresh transport 
buffer (pre-warmed to 37°C) was added to the receiver compartment. TEER was measured 
after pre-incubation and at the end of the experiment. 
 
Transport of RITC-labelled nanoparticles were quantified via a fluorescence plate reader 
(Infinite M200, Tecan, Crailsheim, Germany) using an excitation wavelength of 560 nm and 
an emission wavelength of 600 nm. Fluorescence of RITC was linear in a range between 0.05 
and 100 µg/ml (R2=0.9992). As a result, the amount of substance in the acceptor compartment 
as well as the apparent permeability (Papp) were calculated. The apparent permeability 
describes the permeability of a cell monolayer for a substance and the estimated membrane 
permeability (cm/sec). It was calculated according to: Papp = (∆Q/∆t)*(1/A)*(1/c0), where 
∆Q/∆t is the permeability rate (µg/min), A (cm2) is the surface area of the monolayer and c0 
(µg/ml) is the nanoparticle concentration in the donor compartment at time (t)=0.  
 
   
A          B 
Figure 4.3: Assembling of a Transwell® system. (A) Caco-2 cells were cultivated on the polycarbonate 
membrane of an insert. Thus, the monolayer separates the chamber into an upper (apical) and a lower 
(basolateral) compartment. (B) Caco-2 monolayer grown on a polycarbonate membrane. Cells were stained with 
FITC-labelled wheat germ agglutinin. Bar=12.00 µm. 
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4.4  RESULTS 
 
4.4.1 Size-, time- and surface modification-dependent association of RITC-labelled 
silica nanoparticles 
Unmodified RITC-labelled silica nanoparticles (N50-RITC, N77-RITC, N94-RITC) with 
different sizes (50, 77 and 94 nm) were dispersed in HBSS to a concentration of 100 µg/ml 
and were incubated with Caco-2 cells for 4 hours under standard cell culture conditions. Flow 
cytometry (FACS) analysis of whole cells presented a clear cell association for N50-RITC 
(85.9% ± 6.05) and N77-RITC (84.9% ± 4.07) particles, whereas N94-RITC particles 
exhibited no or a rather low cell association of 0.4% ± 0.42 (Figure 4.4 A, black bars). 
Prepared nuclei which were still associated with cell fragments showed a decreased cellular 
particle association with a size-dependency: N50-RITC particles demonstrated a cell 
association of 84.9% ± 1.90, whereas N77-RITC particles exhibited only a cell association of 
76.1% ± 4.77 (Figure 4.4 A, white bars). Isolated nuclei demonstrated a highly significant 
reduction (p≤0.001) in particle association when compared to prepared cell nuclei. 
30.7% ± 5.97 of N50-RITC particles and 16.9% ± 7.53 of N77-RITC particles were 
associated with nuclei of Caco-2 cells (Figure 4.4 A, grey bars). The same nanoparticles but 
with an additional PEG modification (N50-P-RITC, N77-P-RITC and N94-P-RITC) showed 
no association with cells or nuclei at all (Figure 4.4 B).  
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Figure 4.4: Size- and surface modification-dependent association of RITC-labelled silica nanoparticles. 
Different nanoparticles were added to Caco-2 cells in a concentration of 100 µg/ml and were incubated for 
4 hours under standard cell culture conditions. HBSS served as a negative control. Whole cells as well as 
prepared and isolated nuclei were analyzed via flow cytometry. (A) Size-dependent association of unmodified 
nanoparticles (N50-RITC, N77-RITC and N94-RITC). (B) Association of PEG-modified nanoparticles (N50-P-
RITC, N77-P-RITC and N94-P-RITC). Data represent the mean ± SD of three independent experiments. The 
asterisks depict significant differences between prepared and isolated nuclei (p≤0.001 ***). 
 
The size- and surface-dependent association of RITC-labelled nanoparticles with Caco-2 cells 
was confirmed via CLSM. It could be demonstrated that N50-RITC and N77-RITC 
nanoparticles were adsorbed to the cell membranes of Caco-2 cells after a 4-hour-incubation 
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(Figure 4.5 A-B, arrows), whereas all other particles were not detectable (Figure 4.5 C-F). A 
series of images at different points along the z-axis (Z-stack) exhibited no or a rather low 
uptake of N50-RITC and N77-RITC particles into the cells (Figure 4.6).  
 
 
Figure 4.5: Size- and surface modification-dependent association of RITC-labelled silica nanoparticles with 
Caco-2 cells. Cells were plated on glass culture slides. Different RITC-labelled nanoparticles (red) were added to 
the cells and were incubated in a concentration of 100 µg/ml for 4 hours under standard cell culture conditions. 
Membranes were stained with FITC-labelled WGA (green). After fixation with 4% formalin, nuclei were stained 
with DAPI (blue). Analysis was performed via CLSM. (A) Unmodified nanoparticles N50-RITC, 50 nm. 
(B) Unmodified nanoparticles N77-RITC, 77 nm. (C) Unmodified nanoparticles N94-RITC, 94 nm. (D) PEG-
modified nanoparticles N50-P-RITC, 55 nm. (E) PEG-modified nanoparticles N77-P-RITC, 87 nm. (F) PEG-
modified nanoparticles N94-P-RITC, 97 nm. Bars=14.00 µm. 
A B C 
D E F 
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A         B 
Figure 4.6: Size-dependent association of RITC-labelled silica nanoparticles with Caco-2 cells. Cells were 
cultured on glass culture slides. Nanoparticles (red) were added to the cells and were incubated in a 
concentration of 100 µg/ml for 4 hours under standard cell culture conditions. Membranes were stained with 
FITC-labelled WGA (green). After fixation with 4% formalin, nuclei were stained with DAPI (blue). Analysis 
was performed via CLSM. (A) Unmodified nanoparticles N50-RITC, 50 nm. (B) Unmodified nanoparticles 
N77-RITC, 77 nm. Besides an XY image, XZ- and YZ-cross sections through an image stack were performed as 
well. Bars=14.00 µm.  
 
Furthermore, N50-RITC and N77-RITC particles demonstrated a time-dependent cell 
association over 8 hours. Cellular association of N50-RITC and N77-RITC particles differed 
mainly in the early stage of the experiment. After a 1-hour-incubation 78.4% ± 0.62 of the 
cells were associated with N50-RITC particles, whereas only 45.4% ± 6.81 of the cells were 
in contact with N77-RITC particles (Figure 4.7, black bars). After a 4-hour-incubation, the 
association rate of these two particles differed about 3.8% (Figure 4.7, white bars). After 
4 hours the cellular association reached a plateau. Therefore, a significant difference in the 
cellular association rate of nanoparticles was only observed after an incubation of 1 hour and 
after a 4-hour-incubation.  
 4          Binding, association and transport of silica nanoparticles 77 
 
 
 
Figure 4.7: Time-dependent association of RITC-labelled silica nanoparticles with Caco-2 cells. Different 
nanoparticles (N50-RITC and N77-RITC) were added to Caco-2 cells in a concentration of 100 µg/ml and were 
incubated for 1, 4 or 8 hours. Whole cells were analyzed via flow cytometry. Data represent the mean ± SD of 
three independent experiments. The asterisks depict significant differences between cells incubated with 
nanoparticles for 1 hour and cells incubated with nanoparticles for 4 hours (p≤0.05 *). 
 
 
4.4.2 Removal of nanoparticles adsorbed to the outer cell membrane 
FACS measurements do not allow a differentiation between nanoparticles adsorbed to the 
outer cell surface and nanoparticles internalized into a cell. Thus, a measured fluorescence 
signal of a cell comprises nanoparticles which entered the cell as well as nanoparticles, which 
are only adsorbed to the outer cell membrane (Figure 4.8). Therefore, in this study, different 
buffers were used to remove particles from the outer cell membrane to consequently measure 
only cellular internalized nanoparticles. 
 
 
Figure 4.8: Flow cytometry fluorescence signals of Caco-2 cells incubated with RITC-labelled nanoparticles. 
The generated signal is independent of the cellular localization of nanoparticles.  
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Caco-2 cells showed already after a 1-minute-incubation with RITC-labelled nanoparticles a 
very high fluorescence signal. As this short incubation time excludes an uptake of the 
particles into the cell, the signal resulted from nanoparticles adsorbed to the outer cell 
membrane. Cells with adsorbed nanoparticles were washed with different buffers for several 
times. Afterwards, cells were analysed via flow cytometry. Figure 4.9 summarizes the 
removal potential of the different buffers.  
          
 
           
 
           
 
Figure 4.9: Washing experiments for the removal of nanoparticles from the outer cell membrane. Caco-2 cells 
were incubated for 1 minute with unmodified RITC-labelled nanoparticles (N25-RITC). Subsequently, cells 
were washed three times or were incubated for several times with different buffers. Unwashed cells served as 
control (dashed line). (A) pH 5 buffer. (B) trypsin. (C) 0.0001% triton-X. (D) 0.001% triton-X. 
(E) 0.5 mg/ml pronase. (F) 1 mg/ml pronase. 
A        pH 5 buffer B       Trypsin 
C        0.0001% Triton-X D      0.001% Triton-X 
E        0.5 mg/ml Pronase F      1 mg/ml Pronase 
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Trypsin and pronase buffers could not remove any particles from the cells. Triton-X could 
eliminate some particles but resulted in massive cell damage due to its permeabilization 
characteristics. The pH 5 buffer caused an incubation time-dependent removal of 
nanoparticles from the outer cell surface. However, after 90 minutes the amount of 
nanoparticle associated cells was reduced to only 70%. A longer incubation with the pH 5 
buffer to delete more particles was not possible because of its unphysiological pH causing 
deleterious effects on cells.   
 
 
4.4.3 Transport properties of RITC-labelled silica nanoparticles 
As HBSS was used as transport buffer during transport studies, the barrier function of Caco-2 
cells in HBSS had to be documented. Therefore, long-term measurements with the 
CellZscope® instrument were performed. The TEER of a Caco-2 monolayer incubated in 
HBSS was sustained for 40 hours. Afterwards the TEER declined rapidly (data not shown). 
This experiment demonstrated that Caco-2 monolayers built a tight barrier in HBSS up to an 
incubation time of 40 hours, which allows an examination of the nanoparticulate transport 
during this period. 
 
The passage of different RITC-labelled nanoparticles (N25-RITC, N37-RITC, N62-RITC, 
N50-RITC, N50-P-RITC, N94-RITC and N94-P-RITC) across a Caco-2 cell monolayer was 
investigated using Transwell® plates with a polycarbonate membrane with pore sizes of 
0.4 µm. Samples were collected from the acceptor compartment after 4, 8 and 24 hours. In a 
first experiment, the transport behaviour of unmodified RITC-labelled nanoparticles with 
different sizes (N25-RITC, N37-RITC and N62-RITC) without influence of cells was 
investigated over 8 hours. The transport across the blank filter was time- and size-dependent. 
After 8 hours, 6.26% ± 0.31 of N25-RITC particles arrived in the acceptor, the amount of 
N37-RITC particles in the acceptor was 1.69% ± 0.21. In contrast, N62-RITC showed no or a 
rather low transport rate of 0.66% ± 1.36. Furthermore, it could be demonstrated, that the 
passage across the filter started not before a 1-hour-incubation (Figure 4.10 A).  
 
With the influence of Caco-2 cells, the transport rate of the used nanoparticles was reduced 
due to the additional cellular barrier. Compared to the cell-free experiment after 8 hours, N25-
RITC particles showed a decrease in transport of 94.49% (actual transport rate 0.34% ± 0.59), 
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N37-RITC of 97.63% (actual transport rate 0.59% ± 0.04) and the transport of N62-RITC 
particles was reduced of 94.39% (actual transport rate 0.03% ± 0.06), whereby all transport 
rates were below the detection limit of 0.5%. After 24 hours, the transport experiment 
demonstrated a clear size-dependent transport rate: The amount of N25-RITC nanoparticles in 
the acceptor was 7.29% ± 1.75 of the initial particle concentration. The transport rate of N37-
RITC particles was 0.94% ± 0.08 and the one of N62-RITC nanoparticles was 0.04% ± 0.06 
which was below the detection limit (Figure 4.10 B). TEER values were stable during the 
whole experiment (data not shown). 
 
A            B 
Figure 4.10: Transport of RITC-labelled silica nanoparticles across a (A) polycarbonate membrane with pore 
sizes of 0.4 µm over 8 hours and (B) an additional Caco-2 cell monolayer over 24 hours. Caco-2 cells were 
cultured for 21 days under standard cell culture conditions. Red dashed lines indicate the detection limit of the 
used nanoparticles. Data represent the mean ± SD of three wells.  
 
Another transport experiment with unmodified RITC-labelled nanoparticles (N50-RITC and 
N94-RITC) and PEG-modified nanoparticles (N50-P-RITC and N94-P-RITC) showed again a 
size-dependent transport as well as a surface-modification-dependent effect. N50-RITC 
particles showed after 24 hours a transport rate of 1.66% ± 0.19 and N94-RITC nanoparticles 
exhibited a transport of 1.11% ± 0.13. In contrast, PEG-modified nanoparticles demonstrated 
no or a very low transport across the Caco-2 cell monolayer. After 24 hours, 0.48% ± 0.09 of 
N50-P-RITC and 0.61% ± 0.06 of N94-P-RITC particles were transported across the cells 
(Figure 4.11). These transport profiles were reflected in the Papp values as well (Table 4.2). 
TEER values were stable during the whole experiment (data not shown).  
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Figure 4.11: Transport of unmodified and PEG-modified RITC-labelled silica nanoparticles across a Caco-2 cell 
monolayer cultured for 21 days on polycarbonate membranes with pore sizes of 0.4 µm. (A) Unmodified 
nanoparticles N50-RITC, 50 nm. (B) PEG-modified nanoparticles N50-P-RITC, 55 nm. (C) Unmodified 
nanoparticles N94-RITC, 94 nm. (D) PEG-modified nanoparticles N94-P-RITC, 97 nm. Red dashed lines 
indicate the detection limit of the used nanoparticles. Data represent the mean ± SD of two wells.  
 
Table 4.2: Papp values of unmodified and PEG-modified RITC-labelled silica nanoparticles across a Caco-2 cell 
monolayer.  
Nanoparticle Papp (cm/sec) 
N50-RITC 4.26x10-8 
N50-P-RITC 2.12x10-8 
N94-RITC 3.94x10-8 
N94-P-RITC 2.06x10-8 
 
 
A      N50-RITC B       N50-P-RITC 
C      N94-RITC D     N94-P-RITC 
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4.5 DISCUSSION 
 
Nanoparticles exhibit a broad promising spectrum of potential applications in the 
pharmaceutical and medical field. Typical challenges of drug delivery such as solubility, 
diffusivity, blood circulation half-life and drug release characteristics could be influenced 
with materials in the nanoscale range. Hitherto, a number of nanoparticulate therapeutics and 
diagnostic agents have been developed, e.g. for the treatment of cancer or diabetes (Brannon-
Peppas & Blanchette, 2004; Hirsch et al., 2003; Lin et al., 2007). The advantages of these 
“nanodrugs” are their higher bioavailability and their lower therapeutic toxicity resulting in a 
reduction of side effects. Furthermore, nanoparticulate delivery systems allow a targeted 
delivery and a controlled release. Because of the improvements of all these parameters, it is 
possible to administer these drugs also via more convenient routes, e.g., the oral route. 
However, for the application in this field, the cellular binding, association, the uptake 
properties and the localization of nanoparticles within the cell have to be investigated in 
detail. Especially, the quantification of cellular uptake is a sparely explored topic but is very 
important for the comparison of different studies. However, most publications dealing with 
particle uptake utilize microscopic methods such as confocal laser scanning microscopy 
(CLSM) or transmission electron microscopy (TEM) (Behrens et al., 2002; Beisner et al., 
2009; Chen & Mikecz von, 2005; Taetz et al., 2009). Hitherto, there are a few studies using 
flow cytometry (FACS) as quantitative method (Gabor et al., 2008; Taetz et al., 2009). A 
study of Gabor et al. managed this challenge by analysing the changes in granularity via 
analysing the sideward scatter signal in flow cytometry measurements. As a result, the mean 
granularity of Caco-2 cells was increased due to the cellular association of nanoparticles 
(Gabor et al., 2008). However, this measurement parameter was not applicable for the silica 
nanoparticles used in the present study. These particles did not cause any alteration in the 
sideward scatter signal (data not shown), although they showed a clear increase in the FL2 
fluorescence signal.  
 
RITC-labelled silica nanoparticles exhibited a size- and time-dependent cellular and nuclear 
association to Caco-2 cells. Such a size dependency could be already observed for 
fluorescently-labelled silica nanoparticles sized between 40 nm and 5 µm in Hep-2 cells or 
nuclei which could be determined via CLSM (Chen & Mikecz von, 2005). Small unmodified 
nanoparticles (N50-RITC and N77-RITC) seemed to be in a strong association with cell 
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membranes, whereas larger and PEG-modified nanoparticles did not show these cellular 
interactions. These results represent one important characteristic of PEG. In vivo, PEGylation 
of nanoparticles results in a blocking of the adhesion of opsonin proteins present in the blood 
serum (Peracchia et al., 1999; Peracchia et al., 1999). A similar mechanism could play a role 
in the decreased cellular association of PEG-modified nanoparticles in vitro. Obviously 
proteins, which are involved in the docking of particles to the cell membrane, could not 
adhere to particles due to PEGylation of the particle surface. In this context, similar results 
could be observed in recent publications. PEG-modified poly lactic acid nanoparticles 
exhibited no interaction with Caco-2 cells in contrast to unmodified hydrophobic polystyrene 
nanoparticles which showed a very strong cellular association (Behrens et al., 2002). The 
coating of polystyrene nanoparticles with a poloxamer, leading to an increased hydrophilicity, 
caused a reduction in intestinal uptake as well (Hillery & Florence, 1996). These findings 
confirm the hypothesis which suggested that the association between nanoparticles and cell 
membranes are based on hydrophobic interactions (Lehr et al., 1991). Thus, surface 
modifications with hydrophilic molecules avoid the cellular association and consequently the 
uptake into the cells. This reaction is useful avoiding the elimination by macrophages but 
could be an obstruction when the uptake into other cell types is requested e.g. in the treatment 
of tumour cells. Therefore, nanoparticles need further highly specific surface modifications to 
target their cell-specific transport. 
 
Results of these cell association studies correlate with performed cytotoxicity studies. N50-
RITC particles caused a clear decrease in cellular viability over time. In contrast, 
nanoparticles which showed no association with Caco-2 cells (N50-P-RITC, N94-RITC and 
N94-P-RITC) exhibited no cytotoxic potential. The generation of a cytotoxic effect 
necessitates a close contact between nanoparticles and the biological system. Thereby, mainly 
size, time and surface modification but also the particle concentration influenced the extent of 
the cytotoxic effect (compare to chapter 3) (Gu et al., 2009; Napierska et al., 2009; Pan et al., 
2007; Win & Feng, 2005).  
 
Most research groups, which investigate cellular uptake of nanoparticles, present their data in 
a qualitative way such as CLSM. The advantage of this method is the possibility to visualize 
particle uptake using Z-stack tools. Thus, adsorbed particles can be distinguished from 
internalized particles. This distinction is not possible with flow cytometry measurements 
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using conventional fluorescence dyes such as RITC or FITC. However, for a better 
comparison between different studies it is of great interest to quantify nanoparticulate uptake 
as well. Besides the ability to quantify cellular interactions of nanoparticles, flow cytometry 
measurements show another advantage over confocal microscopy analysis regarding the 
detection limit. CLSM images of Caco-2 cells incubated with N50-RITC particles in a 
concentration of 100 µg/ml, resulted in a low number of detectable nanoparticles. N50-RITC 
particles in a concentration of 50 µg/ml could not be visualized anymore via CLSM. In 
contrast, flow cytometry studies showed no alteration in the emitted fluorescence (indication 
for cellular association), when incubating cells with N50-RITC particles in various 
concentrations (20-100 µg/ml). N50-RITC particles in a concentration of 10 µg/ml still 
exhibited a clearly detectable fluorescence signal in flow cytometry studies. As a result, flow 
cytometry measurements allow a more sensitive determination of the nanoparticulate 
association as CLSM. 
 
As mentioned before, most fluorescently-labelled nanoparticles, such as RITC-labelled 
nanoparticles, have the disadvantage that it is not possible to distinguish between internalized 
and adsorbed particles in a quantitative way (e.g. via flow cytometry). Whole cells which 
exhibit a fluorescence signal via flow cytometry can be associated with nanoparticles in two 
different ways: Either particles are adsorbed to the outer cell surface or are taken up into the 
cells. RITC-labelled nanoparticles showed already after a very short incubation time of 
1 minute a high fluorescence signal due to particles associated with the outer cell membrane. 
Thereby, the short incubation time excluded an uptake into the cell which could also be 
confirmed via CLSM. Hitherto, there are a few publications dealing with this question. In 
recent studies, the resulting fluorescence of adsorbed FITC-labelled nanoparticles was 
quenched with trypan blue which has been demonstrated to quench the fluorescence of FITC-
labelled compounds (Huang et al., 2004; Ma & Lim, 2003; Sahlin et al., 1983). However, this 
method requires an addition of a supplemental reagent which can again result in interactions 
with nanoparticles. Due to their chemical properties nanoparticles often show strong 
interactions with a lot of standardized chemicals. Therefore, it is suggested to avoid the 
application of additional reagents (Wahl et al., 2008; Worle-Knirsch et al., 2006). 
Furthermore, these methods give no information about the localization of the particles within 
the cell. The performed washing experiments for the removal of nanoparticles from the outer 
cell membrane failed. Contents of the used buffers were very aggressive and caused fatal cell 
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damages which resulted in the loss of the barrier function. However, a promising approach 
allowing a distinction between internalized and adsorbed nanoparticles will be discussed in 
chapter 5. 
 
Transport experiments correlated with conducted cell association studies since the transport 
rate of silica nanoparticles was related to their cellular association. The transport rate is as 
well size- and time-dependent, whereupon the transport of PEG-modified nanoparticles was 
very low. These results were conceivable, as particles showing no or a very low association to 
the outer cell membrane, could not be internalized and consequently could not be transported 
across a cell monolayer. The transport speed of nanoparticles was very low. Compared to the 
compound [14C]mannitol, which is a drug belonging to class 4 (drugs with low solubility and 
low permeability) of the Biopharmaceutic Classification System (BCS), a guidance for 
predicting the intestinal drug absorption, the used nanoparticles were transported even slower. 
Mannitol demonstrated a Papp of 1.77x10-7 cm/sec (Hidalgo et al., 1989), silica nanoparticles 
were in the range of 2.06x10-8 to 4.26x10-8 cm/sec.  
 
Various studies suggested that the uptake and the following transport across the intestinal 
epithelial barrier may not occur in enterocytes but in the intestinal M cells. M cells are parts 
of the follicle associated epithelium which covers the Peyer’s patches. They consist of a small 
amount of microvilli which can result in a reduced clearance of adsorbed particles. 
Furthermore, M cells are able to internalize antigens, macromolecules such as bacteria or 
viruses and also nanoparticles from the apical side in an endocytotic process (Clark et al., 
2001; Frey & Neutra, 1997). Therefore, M cells present the potential portal for oral delivery 
of nanoparticles and should be investigated in detail and should be attracted more notice in 
further studies (des Rieux et al., 2005; Kraehenbuhl & Neutra, 2000). Des Rieux et al. dealt 
with this topic and developed an in vitro model for the human intestinal follicle associated 
epithelium which could be a promising starting point for research in this area (des Rieux et 
al., 2005).  
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4.6 CONCLUSION 
 
The identification of potential drug candidates and the treatment of diseases like cancer by 
new methods such as antisense therapy assign new tasks for the pharmaceutical 
nanotechnology. Thereby, cellular binding, association, uptake, transport and localization of 
nanoparticles are important parameters in the field of nanoparticulate drug or gene delivery. 
For a better comparison of different materials and applications it is of great interest to 
quantify the uptake and the localization of these nanoparticulate carriers. The size of the 
particles as well as their surface modifications had an essential function in the association and 
transport of these novel materials. However, the differentiation between adsorbed and 
internalized nanoparticles is still a problem. Therefore, the next step in this research field was 
the finding of new approaches for a clear distinction between nanoparticles associated with 
the outer cell surface and particles, which are taken up into the cell. As the removal of 
nanoparticles by the means of different washing buffers failed, the answer to this problem was 
found in the labelling of the particles in principle (see chapter 5).
 5 
Cellular uptake and localization of propidium 
iodide-labelled silica nanoparticles. 
 
 
Parts of this chapter have been submitted or are in preparation for publication as journal 
articles: 
1. A. Neumeyer, M. Bukowski, M. Veith, C.-M. Lehr & N. Daum. PI-labelling of nanoparticles 
as novel tool for the quantification of cellular binding and uptake. Submitted to 
Nanomedicine: Nanotechnology, Biology and Medicine 
 
2. A. Neumeyer, M. Bukowski, M. Veith, C.-M. Lehr & N. Daum. Identification of the 
endocytotic mechanisms involved in the cellular uptake of silica nanoparticles. In 
preparation. 
 
For a closer investigation of the cellular uptake and localization of nanoparticles within Caco-
2 cells, particles with adsorbed propidium iodide (PI) were prepared. These particles only give 
a fluorescence signal when associated with DNA or RNA. Consequently, particles adsorbed 
to the outer cell surface are not detected, whereas internalized particles exhibit a clear 
fluorescence signal. Flow cytometry measurements demonstrated that PI-labelled 
nanoparticles with a size of 21 nm showed a clear time-dependent uptake into the cell. Further 
experiments exhibited that a PI signal could be detected in the cytoplasm and less in the 
nucleus, what could be confirmed via confocal microscopy. Furthermore, this approach 
allowed the identification of cellular endocytosis mechanisms involved in the uptake of 
nanoparticles in a quantitative way. In addition, the carrier function of silica nanoparticles 
could be demonstrated by comparing the cellular uptake of free PI and nanoparticle-bound PI. 
Free PI was not able to enter Caco-2 cells, whereas PI bound to nanoparticles showed a clear 
internalization. In summary, the PI-labelling of nanoparticles in combination with flow 
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cytometry measurements are an innovative and promising tool for the quantification of 
nanoparticulate uptake.  
 
 
 
5.1 INTRODUCTION 
 
Nanoparticles provide innovative characteristics as drug carrier. Nanoparticle-encapsulated or 
-adsorbed drug molecules show a remarkably increased bioavailability by improving the 
overcoming of several biological barriers. In this context, silica nanoparticles show various 
advantages. They are non-toxic, can be easily surface modified, are insensitive to 
microorganisms and show high pH stability. Recent studies already demonstrated an uptake of 
silica nanoparticles in cells and nuclei using confocal microscopy (Chen & Mikecz von, 2005; 
Peng et al., 2006; Vallhov et al., 2007). However, there is a lack of studies which determine 
the nanoparticulate uptake in a quantitative way. The quantification in this field of application 
is essential, especially, when different materials or studies should be compared.  
 
Most fluorescent labellings (such as Rhodamine B-isothiocyanate, RITC) (compare to 
chapter 4) lack the possibility to distinguish between particles internalized into the cell and 
particles adsorbed to the outer cell surface via quantitative analysis (e.g. flow cytometry). To 
allow a distinction between internalized and adsorbed particles as well as to obtain 
information about the cellular localization, propidium iodide (PI)-labelled nanoparticles were 
prepared. These nanoparticles only emit fluorescence when associated with DNA or RNA. 
Consequently, ingested nanoparticles generate a signal, whereas particles adsorbed to the 
outer cell membranes are not detected.  
 
By means of this novel staining, it is possible to explore the uptake of nanoparticles in more 
detail, receive information about the cellular localization and clarify in a quantitative way the 
cellular endocytosis mechanisms which are involved in the nanoparticulate internalization. 
For an efficient optimization of nanoparticulate carriers it is very important to profile their 
cellular uptake, because this determines their intracellular transport and fate. For the uptake of 
nanocarriers two main internalization pathways are described: either the phagocytosis or 
endocytosis pathways such as clathrin- and caveolae-mediated endocytosis. Thereby, 
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phagocytosis occurs primarily in specialized cells like macrophages, monocytes, neutrophils 
or dendritic cells. But also epithelial and endothelial cells have been described to show some 
phagocytic activity. In contrast to phagocytosis, endocytic pathways occur in all cells and can 
be divided into three groups: clathrin-mediated endocytosis, caveolae-mediated endocytosis, 
and other clathrin- and caveolae-independent pathways (Conner & Schmid, 2003; Hillaireau 
& Couvreur, 2009; Rabinovitch, 1995). With means of endocytosis inhibitors, the 
mechanisms involved in the uptake of nanoparticles could be identified. Cytochalasin D is a 
cell permeable and potent inhibitor of actin polymerization of the class of mycotoxins (May et 
al., 1998). As phagocytosis is an actin-based mechanism, cytochalasin D can inhibit the 
uptake of particles via this pathway (Lamaze & Schmid, 1995; Parton et al., 1994). The 
clathrin-dependent endocytosis can be prevented via cellular incubation with chlorpromazine. 
Chlorpromazine is a lipophilic phenothiazine derivative which easily binds with membranes 
and proteins. As a result it inhibits the clathrin-coated pit formation by reversible 
translocation of clathrin and its adapter proteins from the outer cell membrane to intracellular 
vesicles (Diaz-Moscoso et al., 2010; Wang et al., 1993). The caveolae-dependent pathway is 
obstructed via nystatin, a polyene antifungal drug which sequesters cholesterol and thus, 
causes a depletion of cholesterol. As cholesterol is needed for the maintaining of caveolae 
development, the mentioned pathway is inhibited (Lamaze & Schmid, 1995; Rothberg et al., 
1990). Monensin, a polyether ionophore antibiotic inhibits caveolae- and clathrin-independent 
mechanisms by preventing the transition of mid and late endosomes to lysosomes and 
avoiding an endosome acidification (Basu et al., 1981; Mollenhauer et al., 1990). Figure 5.1 
gives an overview of all mentioned endocytosis pathways. 
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Figure 5.1: Summary of endocytotic pathways. Large particles can be taken up by phagocytosis, which is a 
process dependent on actin-mediated remodelling of the cell membrane. Particles can be endocytosed by 
different mechanisms that are independent of the coating protein clathrin and dynamin as well (non-clathrin/non-
caveolin endocytosis). Most internalized molecules are delivered to the early endosome via clathrin- or caveolin-
coated vesicles that are derived from the cell membrane (clathrin- or caveolin-dependent endocytosis).  
 
 
 
5.2 AIM OF THE STUDY 
 
The aim of this study was to allow the differentiation between particles adsorbed to the outer 
cell membrane and particles taken up into the cell or the nucleus. Afterwards, the uptake 
properties and the involved uptake mechanisms of PI-labelled silica nanoparticles with 
different sizes and surface modifications should be evaluated in a quantitative way using flow 
cytometry.  
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5.3 MATERIALS AND METHODS 
 
5.3.1 Materials 
Dulbecco’s modified eagle medium (DMEM) with high glucose (4.5 g/l) and L-glutamine 
was obtained from Gibco (Karlsruhe, Germany), fetal bovine serum was purchased from 
PAN-Biotech (Aidenbach, Germany), non-essential amino acids were obtained from PAA 
(Cölbe, Germany). Composition of Hank’s balanced salt solution (HBSS) was as follows: 
136.9 mM NaCl, 5.4 mM KCl, 4.26 mM NaHCO3, 0.34 mM Na2HPO4*7H2O, 
0.35 mM KH2PO4, 5.5 mM glucose, 10 mM HEPES, 1.26 mM CaCl2, 0.5 mM MgCl2*6H2O, 
and 0.4 mM MgSO4*7H2O. HBSS was adjusted to pH 7.4 by means of NaOH. Phosphate 
buffered saline (PBS) was as follows: 129 mM NaCl, 2.5 mM KCl, 7 mM Na2HPO4*7H2O 
and 1.3 mM KH2PO4. PBS was adjusted to pH 7.4 by means of NaOH, as well. Citric acid, 
tween 20, thiazolyl blue tetrazolium bromide, bovine serum albumin and propidium iodide 
(PI) were obtained from Sigma (Munich, Germany). RNase A was obtained from Qiagen 
(Hilden, Germany) and FITC-labelled wheat germ agglutinin (WGA) was purchased from 
Vector Laboratories (Burlingame, CA). Culture slides were obtained from BD Falcon 
(Franklin Lakes, NJ). Centrisart® centrifugation vials were purchased from Sartorius 
(Goettingen, Germany).  
 
 
5.3.2 Caco-2 cell culture 
 The human colon adenocarcinoma cell line, Caco-2, clone C2Bbe1, was purchased from 
American Tissue Culture Collection (ATCC, Manassas, VA) and used at passages 60-80. 
Cells were cultured in Dulbecco’s modified eagle medium (DMEM) with high glucose 
(4.5 g/l) and L-glutamine, supplemented with 10% fetal calf serum (FCS) and 1% non-
essential amino acids and were maintained under standard culture conditions at a temperature 
of 37°C and in a humidified atmosphere of 5% CO2. The culture medium was changed three 
times a week. 
 
 
5.3.3 Stability of the binding between PI and silica nanoparticles 
The stability of the binding between the fluorescence dye PI and the silica nanoparticles were 
analysed dispersing PI-labelled silica nanoparticles in a concentration of 100 µg/ml in HBSS 
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with different pH values (5.0, 5.5, 6.0, 6.5, 7.0 and 7.4). Nanoparticle dispersions were 
incubated for 4 hours under standard cell culture conditions. Afterwards, they were 
centrifuged using Centrisart® centrifugation vials with a molecular weight cut off of 5 000 
Dalton. Supernatants of the different dispersions were analysed via fluorescence 
measurements with an emission filter of 617 nm and an excitation filter of 536 nm.  
 
 
5.3.4 Determination of the cellular uptake of PI-labelled nanoparticles via flow 
cytometry 
Quantification of the cellular or nuclear uptake of PI-labelled nanoparticles was determined 
via flow cytometry as described before in chapter 4 (compare 4.3.4) with the introduced cell 
preparation protocols (compare 4.3.5). Emitted light resulting from internalized PI-labelled 
nanoparticles was detected by the FL3 detector. For a distinction between active and passive 
uptake mechanisms, uptake experiments were performed at a temperature of 4°C as well.  
 
 
5.3.5 PI-labelled nanoparticles as carriers for PI 
One characteristic of PI is that it is excluded from viable cells and is not capable to cross 
intact cell membranes. Therefore, it could be used as a model substance for drugs with a low 
bioavailability and it could be tested if silica nanoparticles could improve the transport of a 
membrane impermeable compound like PI. For this purpose, Caco-2 cells were incubated 
with nanoparticle-bound PI as well as with free PI in solution. The concentration of the used 
unbound PI was equivalent to the amount of PI associated with N21-PI nanoparticles in 
respective concentrations (Table 5.1).  
 
Table 5.1: Concentrations of PI-labelled nanoparticles (N21-PI) (µg/ml) and the corresponding concentrations 
of free PI (ng/ml). 
N21-PI concentration  
(µg/ml) 
Free PI concentration  
(ng/ml) 
1 0.00727 
10 0.0727 
50 0.364 
100 0.727 
200 1.45 
500 3.64 
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5.3.6 Determination of the cellular localization of PI-labelled silica nanoparticles via 
RNase 
The binding characteristics of PI allow a distinction between nanoparticles localized in the 
nucleus and nanoparticles localized in the cytoplasm. For this purpose, cells were pre-
incubated with RNase A to enzymatically degrade the ribose backbone of the RNA and 
thereby eliminating RNA molecules. In contrast, DNA molecules were not influenced by this 
RNase treatment. As a result PI-labelled nanoparticles were not able to bind to RNA anymore 
but had the continuing ability to intercalate into DNA. DNA is predominantly located in the 
nuclei, whereas RNA is found in the form of mRNA and tRNA and furthermore in small 
quantities as pre-mRNA and snRNA in the cytoplasm (Barciszewski & Clark, 1999). Thus, a 
fluorescence signal (e.g. via flow cytometry) generated after pre-incubation with RNase was 
due to an association of PI-labelled nanoparticles with DNA indicative for an uptake into the 
nucleus (Table 5.2). 
 
Table 5.2: Dependency between PI fluorescence and localization of PI-labelled silica nanoparticles 
(with/without RNase pre-incubation). 
 without RNase with RNase 
cellular 
localization 
 
 
fluorescence signal 
 
 
no signal 
nuclear 
localization 
 
 
fluorescence signal 
 
 
fluorescence signal 
 
 
5.3.7 Determination of the cellular uptake mechanisms of silica nanoparticles 
For the clarification of the endocytosis mechanisms involved in the cellular uptake of silica 
nanoparticles, different endocytosis inhibitors (cytochalasin D, chlorpromazine, nystatin and 
monensin) were used. Stock solutions of these inhibitors were diluted to a final concentration 
of 5 mg/ml in DMSO (cytochalasin D and chlorpromazine), water (nystatin) or ethanol 
 5          Uptake and localization of silica nanoparticles 94 
 
 
(monensin). Table 5.3 summarizes the used endocytosis inhibitors and the corresponding 
inhibited pathways. To investigate the involved uptake mechanisms, Caco-2 cells were pre-
incubated with the mentioned endocytosis inhibitors in different concentrations (Table 5.3) 
for 2 hours. Subsequently, PI-labelled nanoparticles with different sizes (21-84 nm) were 
added to the cells. Afterwards, cells were prepared as described before (compare 4.3.5) and 
were analysed via flow cytometry. 
 
Table 5.3: Endocytosis inhibitors and their corresponding inhibited endocytosis pathways.  
Endocytosis inhibitors Inhibited endocytosis pathway Used concentrations 
Cytochalasin D Phagocytosis 1, 5 and 10 µg/ml 
Chlorpromazine Clathrin-dependent pathway 5, 10 and 20 µg/ml 
Nystatin Caveolae-dependent pathway 1, 10 and 20 µg/ml 
Monensin Caveolae- and clathrin-independent 
pathways 
5, 15 and 30 µg/ml 
 
 
 
5.4 RESULTS 
 
5.4.1 PI-labelling allows a clear distinction between adsorbed and internalized silica 
nanoparticles 
As mentioned before, most fluorescently-labelled nanoparticles, such as RITC-labelled 
nanoparticles, have the disadvantage that it is not possible to distinguish between internalized 
and adsorbed particles in a quantitative way (e.g. via flow cytometry). Whole cells which 
exhibited a fluorescence signal via flow cytometry can be associated with nanoparticles in two 
different ways: either particles are adsorbed to the outer cell surface or cells contain of 
internalized particles. The main advantage of PI is that its basic fluorescence is increased by 
20 to 30 fold if it is integrated between bases of DNA or RNA strands. As a result, 
nanoparticles which are located at the outer cell surface and which are not in any contact with 
DNA or RNA generate no fluorescence signal. In contrast, nanoparticles which have entered 
the cells and have the possibility to intercalate between DNA or RNA bases emit a 
fluorescence signal. To proof this concept, PI-labelled nanoparticles as well as RITC-labelled 
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nanoparticles with similar sizes (21 and 25 nm) were incubated with Caco-2 cells for 
1 minute. This short incubation time excluded an uptake of nanoparticles into the cells which 
could also be confirmed by CLSM (data not shown). RITC-labelled nanoparticles showed 
already after this short 1-minute-incubation a high fluorescence signal (Figure 5.2 A) due to 
particles associated with the outer cell membrane. In contrast, PI-labelled nanoparticles 
incubated for 1 minute showed no signal at all due to their localization at the outer cell 
surface, where DNA or RNA was absent (Figure 5.2 B). 
 
 
A            B 
Figure 5.2: Fluorescence signal of RITC- and PI-labelled silica nanoparticles. Nanoparticles were added to 
Caco-2 cells for 1 minute. Afterwards, cells were washed three times with PBS and were analyzed via flow 
cytometry. Histograms are the result of 10 000 analysed cells. HBSS treated cells served as a negative control 
(dashed line). (A) RITC-labelled nanoparticles (RITC-NPs) were detected with FL2 and (B) PI-labelled 
nanoparticles (PI-NPs) were detected with FL3.  
 
As the cellular uptake of nanoparticles is strongly associated with an alteration in pH, a 
further experiment investigated the stability of the binding between PI molecules and silica 
nanoparticles at different pH values. The binding between the fluorescence dye PI and the 
nanoparticles was stable for 4 hours in all pH values reaching from 5.0 to 7.4. After a 4-hour-
incubation at 37°C, 0.35% to 1.20% of the PI dye was released from the particles. Due to 
these results, it could be suggested, that the detected fluorescence signals were based on 
nanoparticle-bound PI rather than free PI, released from nanoparticles (Figure 5.3).  
 5          Uptake and localization of silica nanoparticles 96 
 
 
 
Figure 5.3: PI release from PI-labelled silica nanoparticles. PI-labelled nanoparticles were incubated for 4 hours 
in HBSS with different pH values (5.0-7.4). Afterwards, particle dispersions were centrifuged in Centrisart® 
centrifugation vials. Supernatants were analysed using an emission filter of 617 nm and an excitation filter of 
536 nm. The dashed line indicates the maximal amount of PI bound to the used silica nanoparticles.  
 
 
5.4.2 Silica nanoparticles serve as drug carriers for free PI 
A further advantage of PI is that it is excluded from viable cells and is not capable to cross 
intact cell membranes. Therefore, it was tested if silica nanoparticles could improve the 
transport of a membrane impermeable compound like PI. For this purpose Caco-2 cells were 
incubated with nanoparticle-bound PI as well as with free PI in solution. The concentration of 
the used unbound PI was equivalent to the amount of PI associated with N21-PI nanoparticles 
in respective concentrations (Table 5.1). Flow cytometry analysis demonstrated that free PI 
(0.727 ng/ml) is excluded from viable cells over time when compared to N21-PI particles in a 
concentration of 100 µg/ml (100 µg/ml N21-PI particles contain 0.727 ng/ml adsorbed PI) 
(Figure 5.4, grey bars). In contrast, N21-PI particles showed a time-dependent uptake over 
4 hours. After an incubation of 1 hour no or a rather low cellular uptake (0.33% ± 0.14) could 
be detected. After a 2-hour-incubation 2.85% ± 0.57 of the cells contained ingested particles 
12.7% ± 3.75 of the cells were positive for a PI staining after a 4-hour-incubation 
(Figure 5.4, black bars). 
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Figure 5.4: Cellular uptake of PI-labelled silica nanoparticles (N21-PI) and free PI in solution. Caco-2 cells 
were incubated with HBSS, N21-PI nanoparticles (100 µg/ml) or the corresponding concentration of free PI 
(0.727 ng/ml) for 1, 2 and 4 hours. Whole cells were analysed via flow cytometry. Results are the mean 
mean ± SD of three independent experiments.  
 
These fluorescence characteristics of PI could be rechecked via fluorescence measurements. 
Free PI as well as nanoparticle bound PI (N21-PI particles) was incubated for 30 minutes 
without cells or with intact or permeabilized Caco-2 cells. In comparison to the cell-free 
experiment, samples with intact cells showed no increase in fluorescence, whereas 
permeabilized cells demonstrated an increase in the emission. Permeabilized cells allowed a 
contact to DNA and RNA and consequently an alteration in the fluorescence signal 
(Table 5.4).  
 
Table 5.4: Fluorescence characteristics of PI. Free PI as well as PI-labelled nanoparticles (N21-PI) were 
incubated for 30 minutes with intact and triton-X-permeabilized cells. Samples were analyzed using an emission 
filter of 617 nm and an excitation filter of 536 nm.  
Sample Without 
Cells 
Intact 
Cells 
Permeabilized 
Cells 
Free PI 86 99 1072 
PI-labelled nanoparticles (N21-PI) 83 72 434 
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5.4.3 Cellular uptake and localization of PI-labelled silica nanoparticles 
The cellular uptake and also the localization of nanoparticles within the cell are of great 
interest. Within 4 hours, PI-labelled nanoparticles were able to enter Caco-2 cells. Flow 
cytometry analysis demonstrated that 12.7% ± 3.75 of the cells and 3.6% ± 1.89 of the nuclei 
exhibited a PI signal. Triton-X permeabilized cells served as a positive control. The triton-X-
caused cell membrane damage allowed N21-PI particles free access to DNA or RNA within 
the cells. Therefore, the resulted fluorescence signal demonstrated the maximal fluorescence 
caused by PI-labelled nanoparticles (Figure 5.5).  
 
To specify if internalized nanoparticles were localized in the cytoplasm or the cell nucleus, 
cells were pre-incubated with RNase A to enzymatically degrade the ribose backbone of the 
RNA and thereby eliminating RNA molecules. In contrast, DNA molecules were not 
influenced by this RNase treatment. As a result PI-labelled nanoparticles were not able to bind 
to the RNA anymore, but had the continuing ability to intercalate into DNA. DNA is 
predominantly located in the nucleus, whereas RNA is found in the cytoplasm. Thus, a 
fluorescence signal (e.g. via flow cytometry) generated after pre-incubation with RNase must 
be due to an association of PI molecules with DNA indicative for an uptake into the nucleus. 
After a 1-hour-pre-incubation with RNase and a subsequent 4-hour-incubation with N21-PI 
nanoparticles, 5.7% ± 2.92 of Caco-2 cells were labelled with PI. In contrast, 12.7% ± 3.75 of 
the cells were positive for a PI staining without any addition of RNase. These results 
demonstrated that about 6% of the analysed cells contained PI molecules which showed an 
association with DNA indicative for a nuclear uptake. A subsequent isolation of the nuclei 
evidenced these findings. Isolated nuclei did not show a significant difference to RNase pre-
incubated whole cells. In RNase pre-incubated cells, RNA was eliminated enzymatically, 
whereas in isolated nuclei, the cytoplasm and its containing RNA-bound PI-labelled 
nanoparticles were removed mechanically. As a result, only DNA-associated and therefore 
nucleus-localized PI molecules could be detected (Figure 5.5).  
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Figure 5.5: Cellular and nuclear uptake and localization of PI-labelled silica nanoparticles (N21-PI). Caco-2 
cells were incubated with N21-PI nanoparticles in a concentration of 100 µg/ml for 4 hours without or with pre-
incubation of RNase. Whole cells as well as isolated nuclei were analysed via flow cytometry. As a positive 
control cells had been permeabilized with triton-X prior to nanoparticle incubation. HBSS served as negative 
control. Results are the mean ± SD of three independent experiments. The asterisks depict significant differences 
between the different samples (p≤0.05 *).  
 
The significant decrease in the emitted PI signal (p≤0.02) for whole cells after pre-incubation 
with RNase could be also detected via CLSM in a qualitative way (Figure 5.6). As a positive 
control permeabilized cells were stained with free PI in solution (0.727 ng/ml) (Figure 5.6 A) 
which resulted in a clear red staining of the inner cells. As a negative control Caco-2 cells 
were incubated for 1 minute with N21-PI nanoparticles. In this experiment no red staining 
could be detected (Figure 5.6 B), because nanoparticles did not enter the cell during this short 
incubation time. Furthermore, N21-PI nanoparticles were incubated for 4 hours without 
(Figure 5.6 C) or with a previous cellular incubation with RNase for 1 hour (Figure 5.6 D). 
Figure 5.6 C clearly shows a red staining inside the green-labelled cell membranes. The red 
signal inside the cells is an indication for PI-labelled nanoparticles taken up into the cells. 
This fluorescence signal was absent in cells pre-incubated with RNase, because PI could not 
bind to RNA anymore. Obviously, after 4 hours only a low amount of particles or PI 
molecules were able to enter the nucleus, insufficient to cause a detectable fluorescence 
signal.  
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Figure 5.6: Cellular uptake and localization of PI-labelled silica nanoparticles. Caco-2 cells were plated on glass 
culture slides. Cells were incubated with (A) free PI (after fixation), (B) N21-PI particles for 1 minute, (C) N21-
PI particles for 4 hours or (D) N21-PI particles for 4 hours with a pre-incubation of RNase. Membranes were 
stained with FITC-labelled WGA (green) followed by a cell fixation with 4% formalin. Analysis was performed 
via CLSM. Bars=14.00 µm. 
 
 
5.4.4 Identification of the internalization mechanisms involved in the uptake of silica 
nanoparticles 
To proof if nanoparticles were internalized in an active or a passive process, uptake 
experiments were conducted at a temperature of 37°C and a temperature of 4°C as well. For 
this purpose, Caco-2 cells were incubated with N21-PI, N34-PI or N84-PI nanoparticles for 
4 hours under standard cell culture conditions or at a temperature of 4°C. For N21-PI and 
N34-PI particles no uptake inhibition at 4°C in comparison to the uptake rate at 37°C could be 
demonstrated. In contrast, N84-PI particles showed a significantly reduced cellular uptake of 
49.49% ± 16.6 when incubated at a temperature of 4°C (Figure 5.7).  
free PI 1 min N21-PI 
RNase + 4 h N21-PI 4 h N21-PI 
A B 
C D 
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Figure 5.7: Temperature-dependent uptake of silica nanoparticles. Caco-2 cells were incubated for 4 hours with 
different silica nanoparticles (N21-PI, N34-PI and N84-PI) at a temperature of 37°C or 4°C. Cells were analysed 
via FACS. Data show the alteration in the uptake rate compared to control cells incubated at 37°C in HBSS. 
Results are the mean mean ± SD of three independent experiments. The asterisks depict significant differences 
between cells incubated at 4°C and cells incubated at 37°C (p≤0.01 **). 
 
For the clarification of the uptake mechanisms involved in the cellular uptake of 
nanoparticles, Caco-2 cells were incubated with different endocytosis inhibitors. 
Chlorpromazine (clathrin-dependent endocytosis) and nystatin (caveolae-dependent 
endocytosis) showed no inhibition in the uptake rate when compared to cells pre-incubated in 
HBSS instead of an inhibitor (Figure 5.8 A and B). In contrast, cytochalasin D (phagocytosis) 
and monensin (clathrin- and caveolae-independent pathways) demonstrated a concentration-
dependent inhibition in the uptake of nanoparticles into Caco-2 cells (Figure 5.8 C and D).  
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A              B 
   
C              D 
Figure 5.8: Identification of the internalization mechanisms involved in the uptake of silica nanoparticles. Caco-
2 cells were pre-incubated for 2 hours with different endocytosis inhibitors: (A) Chlorpromazine, clathrin-
dependent endocytosis (B) Nystatin, caveolae-dependent endocytosis. (C)  Cytochalasin D, phagocytosis. 
(D) Monensin, caveolae- and clathrin-independent endocytosis. Afterwards, cells were incubated with N21-PI 
(only C and D), N34-PI and N84-PI nanoparticles for 4 hours. Cells were analysed via FACS. Data show the 
alteration in the uptake rate compared to control cells incubated in HBSS instead of an endocytosis inhibitor. The 
asterisks depict significant differences between inhibitor-incubated and control cells (p≤0.05 *, p≤0.01 **). 
Results are the mean mean ± SD of three or two (chlorpromazine) independent experiments.  
 
The inhibition of the nanoparticulate uptake by cytochalasin D and monensin was dependent 
on the used nanoparticle sizes. Nanoparticles with a size of 21 nm (N21-PI) were not 
influenced by these endocytosis inhibitors and exhibited no decreased uptake 
(Figure 5.8 C and D, white bars). In contrast, particles with a size of 34 nm (N34-PI) showed 
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a significantly reduced internalization after cellular pre-incubation with 5 µg/ml monensin 
(Figure 5.8 C and D, black bars). The largest used nanoparticles with a size of 84 nm 
demonstrated the strongest influence by cytochalasin D or monensin. For cytochalasin D as 
well as for monensin a concentration-dependent decrease in the cellular uptake of these 
nanoparticles was documented (Figure 5.8 C and D, grey bars).  
 
 
 
5.5 DISCUSSION 
 
In this study, silica nanoparticles with adsorbed PI served as novel tools for the quantification 
of the cellular uptake. These particles promise a clear differentiation between particles 
associated with the outer cell membrane and particles taken up into the cell. Therefore, this 
nanoparticulate staining in combination with the new established flow cytometry assay, 
demonstrates a promising tool for the quantitative investigation of cellular uptake and 
localization. Especially, the cellular localization and the involved uptake mechanisms are 
essential parameters with regard to toxicity and the future application spectrum.  
 
Silica nanoparticles present potential drug carriers for molecules with a low bioavailability or 
stability. In this study the membrane-impermeable fluorescent dye PI served as a model 
substance. It could be demonstrated that free PI molecules could not overcome intact cell 
membranes due to its chemical composition. In contrast, its binding to silica nanoparticles 
allowed a time-dependent internalization into the cells. This ability of nanoparticles could be 
very helpful in the oral application of cytostatics in cancer therapy. Most anticancer drugs are 
orally not or minimal bioavailable, e.g., the bioavailability of the cytostatic paclitaxel is less 
than 1%. Lipid based nanoparticles already improved the paclitaxel transport across Caco-2 
cells (Roger et al., 2009). In addition, an in vivo study demonstrated an enhanced oral 
bioavailability of paclitaxel via paclitaxel-loaded lipid nanocapsules (Peltier et al., 2006).  
 
As the cellular uptake of nanoparticles is strongly associated with an alteration in pH, a 
further experiment investigated the stability of the binding between PI molecules and silica 
nanoparticles in HBSS with different pH values. Hitherto, various uptake mechanisms had 
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been described as potential cell capture pathways for nanoparticles (Hillaireau & Couvreur, 
2009). All these mechanisms are associated with several specific organelles such as 
endosomes or lysosomes. These organelles are involved in the sequential cellular passage of 
particles. ATP-dependent proton pumps are responsible for the generation of an internal 
acidic environment of these organelles. Thereby, the pH can reach from 5.0 to 6.5 (Mellman 
et al., 1986; Pantarotto et al., 2004; Yamashiro & Maxfield, 1984). Conducted experiments 
investigated the strength of the binding between PI molecules and silica nanoparticles, 
demonstrated a strong association between dye and nanoparticles at different pH values. 
Therefore, it could be suggested that the generated fluorescence signal was based on 
nanoparticle bound PI. In addition, it should be mentioned that e.g., lysosomes possess a 
specific enzymatic content including esterases and cathepsins (Mellman et al., 1986). The 
impact of these enzymes to the stability of the binding between fluorescence dyes and 
particles should clearly be kept in mind. Furthermore, due to mechanic forces during the 
internalization process, there could be a release of PI during nanoparticulate transport through 
the cell as well. Visualization techniques such as scanning electron microscopy could be used 
to clarify this question.  
 
Besides the cellular uptake, also the localization of nanoparticles within the cell is of great 
interest. Especially, drug delivery to the nucleus is an increasing field as the nucleus is a 
promising target, because the cell and transcription machinery is localized there (Breunig et 
al., 2008; Tkachenko et al., 2003). Silica nanoparticles sized between 40 and 70 nm had 
already been reported to penetrate the nuclei of Hep-2 epithelial cells (Chen & Mikecz von, 
2005). Furthermore, gold nanoparticles functionalized with a TAT protein-derived peptide 
sequence could be localized in the nucleus, whereas unfunctionalized nanoparticles were just 
present in the cytoplasm and showed no translocation into the nucleus (de la Fuente & Berry, 
2005). The usage of RNase in combination with the PI-labelling of nanoparticles allowed 
more detailed insights in the cellular localization of these particles. RNase enzymatically 
eliminates RNA molecules, DNA molecules were not influenced by this RNase treatment. As 
a result, PI-labelled nanoparticles were not able to bind to RNA anymore but had the 
continuing ability to intercalate into DNA. DNA is predominantly located in the nuclei, 
whereas RNA is found in the form of mRNA and tRNA in the cytoplasm and furthermore in 
small quantities as pre-mRNA and snRNA in the nucleus (Barciszewski & Clark, 1999). 
Thus, a fluorescence signal (e.g. via flow cytometry) generated after pre-incubation with 
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RNase was due to an association of PI-molecules with DNA indicative for an uptake into the 
nucleus. Results demonstrated that about 6% of the analysed cells contained PI molecules 
which showed an association with DNA indicative for a nuclear uptake. A subsequent 
isolation of the nuclei evidenced these findings. However, the main amount of these particles 
was localized in the cytoplasm. A functionalization of these particles with ligands such as 
nucleus localization signals could increase their target delivery and entry into the nucleus. 
 
Nevertheless, as used silica nanoparticles apparently were able to enter the cell nucleus, 
genotoxicity should be mentioned as well. Recent studies already demonstrated a strong 
association between genotoxic effects, the cellular uptake rate und the intracellular 
localization of silver nanoparticles (Ahamed et al., 2008). Carbon nanotubes showed the 
possibility to cause DNA damage due to their penetration into the cell nucleus (Tkachenko et 
al., 2003). Silica nanoparticles were described as well to enter the nucleus and influence the 
gene expression (Chen & Mikecz von, 2005). Silica nanoparticles with a size of 21 nm caused 
a decrease in cellular viability (compare to chapter 3). Hitherto, the reason of that cytotoxic 
effect could not be clarified. Thereby, a genotoxic effect due to the nuclear localization of 
these particles could not be excluded.  
 
Hitherto, various uptake mechanisms have been described as potential cell capture pathways 
for nanoparticles (Hillaireau & Couvreur, 2009; Luhmann et al., 2008). In general, 
nanoparticles must cross one or more biological membranes before they diffuse across the 
plasma membrane to finally enter the target organelle. Depending on the drug characteristics, 
the chosen uptake pathway as well as the intracellular fate of the drug carrier is essential for 
the efficacy of the drug. Thereby, the release of the drug into the enzymatic environment of 
the lysosomes or the direct release in the cell cytoplasm will dramatically influence the 
pharmacological activity of a drug (Hillaireau & Couvreur, 2009). Mostly, the internalization 
of nanoparticles into macrophages via phagocytosis is documented. Phagocytosis as the 
involved mechanism is described for particles sized between 250 and 3000 nm (Conner & 
Schmid, 2003; Khalil et al., 2006; Mayor & Pagano, 2007).  Whereas, nanoparticles smaller 
than 250 nm were less efficiently internalized via phagocytosis (Korn & Weisman, 1967). 
Phagocytosis is a process which occurs only in highly specialized cells such as macrophages. 
However, also for other cell types a phagocytosis-like mechanism could be demonstrated 
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during the uptake of large cationic-lipid-DNA complexes and PEI polyplexes (Kopatz et al., 
2004; Matsui et al., 1997). Such a phagocytosis-like mechanism could also play a role in the 
conducted uptake experiments in this study. Silica nanoparticles with a size of 84 nm showed 
a significant concentration-dependent uptake reduction after pre-incubation with
cytochalasin D, an inhibitor for phagocytosis. Even, if the size of the particles is not in the 
optimal range of phagocytosis, the inhibition of phagocytosis caused a clear reduction in the 
uptake of silica nanoparticles with a size of 84 nm. This uptake process starts with the 
interaction of particles with specific receptors such as opsonic receptors on the phagocyte. 
This causes an actin assembly and the formation of cell surface extensions that cover the 
particle to engulf it. Subsequently, the particle is internalized and the actin is shed from the 
phagosomes. The resulting phagosome transports the particle through the cytoplasm. 
Afterwards, a series of fusion and fission events begin, which result in the formation of 
mature phagolysosomes where internalized particles are degraded (Khalil et al., 2006). 
Phagocytosis has been traditionally referred to as “cell eating” whereas the non-phagocytic 
endocytosis pathways characterized as “cell drinking” based on their involvement in the 
uptake of fluids and solutes. However, this terminology is not relevant anymore when 
working with nanoparticles. Based on their small size, solid nanoparticles can be internalized 
via these non-phagocytotic pathways which are clathrin-dependent, caveolae-dependent and 
clathrin-/caveolae-independent endocytosis (Hillaireau & Couvreur, 2009). In general, the 
uptake of nanoparticles and the intracellular pathways are dependent on the analyzed cell type 
as well as on the particular size, shape, charge and chemistry of the particles. The uptake of 
poly-L-lysine-PEG-DNA nanocapsules (80-90 nm) in SV 40 transformed kidney cells was 
inhibited by wortmannin (inhibitor for macropinocytosis), genistein and methyl-ß-
cyclodextrin (inhibitor of caveolae-mediated endocytosis). Chlorpromazine (inhibitor of 
clathrin-dependent endocytosis) caused no reduction in the uptake of these particles 
(Luhmann et al., 2008). Thereby, various pathways seem to be involved in the uptake of one 
nanoparticle type and take place simultaneously. Via the use of different endocytosis 
inhibitors, it could be shown that, not only a single uptake pathway is involved, but various 
endocytosis processes interact. The uptake of silica nanoparticles was mediated via 
phagocytosis as well as a clathrin-/ caveolae-independent pathway as the internalization of 
nanoparticles with sizes of 34 and 84 nm were influenced by monensin, an inhibitor for this 
mechanism. A further study demonstrated strong differences in the uptake rate of polystyrene 
particles sized between 20 and 1010 nm in different cell lines. Polystyrene nanoparticles with 
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a size of 20 nm were internalized in a high amount by all used cell types. A murine squamous 
cell line took up particles with sizes of 93, 220- and 560 nm but not with a size of 1010 nm. 
Similar results could be demonstrated for human hepatocyte carcinoma cells and a mouse 
hepatoma cell line. These cells internalized the smaller particles but not the 590- and 1010-nm 
particles. In contrast, human bladder carcinoma cells and primary human umbilical vein 
endothelial cells took up all used particles (Zauner et al., 2001). However, the understanding 
of the role of endocytosis pathways in the internalization of drug delivery nanoparticles is a 
rising research field. The enzymatic content of these endocytotic organelles is a key issue for 
polymeric nanoparticles. Polymeric nanoparticles such as PLGA nanoparticles were degraded 
via a hydrolytic mechanism facilitated by low pH values (Shive & Anderson, 1997). This 
ensures a drug release and avoids a cellular accumulation of these particles which could lead 
to further toxicities (Hillaireau & Couvreur, 2009). In contrast, silica nanoparticles would 
resist such an acidic milieu, which would be important in oral drug delivery. Here, particles 
have to penetrate the intestinal barrier without damage or degradation to enter the blood 
circulation and reach their target tissues.  
 
Endocytosis can be strongly inhibited by lowering the temperature from standard cell culture 
conditions of 37°C to 4°C. At a temperature of 37°C, poly-L-lysine-PEG-DNA nanocapsules 
were found in the cytoplasm, whereas they were located at the outer cell membrane when the 
experiment were performed at 4°C (Luhmann et al., 2008). Caco-2 cells as well as a rat 
gastrointestinal tissue demonstrated a higher internalization of PLGA particles with a size of 
100 nm than for particles sized between 500 nm and 10 µm (Desai et al., 1996; Desai et al., 
1997). Furthermore, the uptake of polystyrene particles with a size of 20 nm was not reduced 
in murine squamous carcinoma cells when incubated at 4°C. In contrast, larger particles (93-
560 nm) showed a size-dependent reduction in the cellular uptake at 4°C. The uptake of 
560 nm polystyrene particles was strongly reduced at 4°C. In contrast, the internalization of 
particles with a size of 93 nm was less reduced (Zauner et al., 2001). These results correlate 
with findings in this study, where a size-dependent reduction in the uptake of nanoparticles at 
a temperature of 4°C could be observed as well. The internalization of PI-labelled silica 
nanoparticles with a size of 21 and 34 nm was not or rather low influenced by endocytosis 
inhibitors. Furthermore, the uptake of these particles was not reduced when experiments were 
performed at a temperature of 4°C in contrast to experiments at 37°C. Silica nanoparticle 
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with a size of 84 nm exhibited a strong reduction of about 50% in their transport rate at 4°C. 
The cellular pre-incubation with inhibitors for phagocytosis (cytochalasin D) and clathrin- and 
caveolae-independent endocytosis (monensin) caused a concentration-dependent increase in 
the uptake of these nanoparticles. Therefore, it is suggested, that the uptake of nanoparticles 
with small sizes (~20-40 nm) is carried out via passive pathways. Larger particles seem to use 
active internalization processes to enter a cell.  
 
 
 
5.6 CONCLUSION 
 
In conclusion, the PI-labelling of nanoparticles in combination with flow cytometry studies is 
a promising tool for the quantification of cellular uptake and localization of nanoparticles in 
vitro. It allows a clear distinction between particles internalized into cells and particles 
adsorbed to the outer cell membrane. Quantitative data allow an easy comparison between 
different studies and facilitate the experimental approach.  
 
PI-labelled nanoparticles with a size of 21 nm showed an uptake into the cell and were even 
able to generate a PI signal in the nucleus indicating a nuclear localization. This allows 
various pharmaceutical applications but should be considered critically as well, as silica 
nanoparticles localized in the nucleus could cause deleterious cellular damage. Further control 
experiments using high resolution visualization techniques such as scanning electron 
microscopy could provide further evidences for a nuclear localization of these particles. 
 
Furthermore, it could be demonstrated that particles with such a small size were internalized 
via passive pathways rather than by endocytotic processes. Active uptake mechanisms such as 
phagocytosis and clathrin- and caveolae-independent pathways seemed to play a role in the 
uptake of larger silica nanoparticles (84 nm).  
 
  
6 
Summary 
 
 
Nanomaterials are innovative tools in the field of oral drug delivery. The main obstacle of this 
application route is the overcoming of the intestinal barrier and the insistence against cells of 
the immune system. An overcoming or circumvention of these barriers would lead to an 
enhancement in the oral bioavailability. One delivery strategy is based on the encapsulation or 
adsorption of drugs and molecules in nanoparticles. Thereby, inorganic nanoparticles such as 
silica nanoparticles provide promising characteristics as novel drug carriers. The modification 
of the nanoparticle surface with poly ethylene glycol (PEG) could avoid a clearance via 
phagocytes and other immune cells. For the application in this field, cellular binding, 
association, uptake properties and localization of nanoparticles within the cell have to be 
investigated in detail. Especially, the quantification of cellular uptake is a sparely explored 
topic, but is very important for the comparison of different studies and materials. Therefore, 
the aim of this study was to evaluate the cellular association, uptake and transport properties 
of fluorescently-labelled silica nanoparticles with different sizes and surface modifications in 
a quantitative way using flow cytometry. Furthermore, these particles had to be evaluated for 
their oxidative and cytotoxic potential.  
 
Flow cytometry analysis demonstrated that rhodamine B-isothiocyanate (RITC)-labelled 
silica nanoparticles sized between 50 and 77 nm exhibited a clear association with Caco-2 
cells. Thereby, nanoparticles with a size of 50 nm were associated with 86% of Caco-2 cells 
and with 31% of isolated nuclei. Nanoparticles with a size of 77 nm showed an association 
rate of 85% with whole cells and 17% with isolated nuclei. In contrast, larger particles with a 
size of 94 nm and PEG-modified nanoparticles with similar sizes showed no or a rather very 
low cellular interaction. Transport experiments correlated with these association studies, as a 
size- and time-dependent transport across a Caco-2 cell monolayer could be observed. Small 
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and unmodified nanoparticles (50 nm) showed the highest transport, whereas PEG-modified 
and larger unmodified nanoparticles (94 nm) were not or rather low transported.  
 
However, the fluorescent labelling with RITC lacks the possibility to distinguish between 
particles internalized into the cell and particles adsorbed to the outer cell surface via flow 
cytometry. To allow a distinction between internalized and adsorbed particles as well as to 
obtain further information about the cellular localization, particles with adsorbed propidium 
iodide (PI) were prepared. These particles only give a fluorescence signal when associated 
with DNA or RNA. Consequently, particles adsorbed to the outer cell surface were not 
detected, whereas internalized particles exhibited a clear fluorescence signal. Flow cytometry 
measurements showed a time-dependent uptake of PI-labelled silica nanoparticles with a size 
of 21 nm. Further experiments with the additional usage of RNase exhibited that PI signals 
could be detected in the cytoplasm and less in the nucleus. RNase enzymatically eliminates 
RNA molecules which are predominantly located in the cytoplasm. As a result, PI-labelled 
nanoparticles were not able to bind to the RNA anymore but had the continuing ability to 
intercalate into DNA, predominantly located in the nuclei. Thus, a fluorescence signal 
generated after pre-incubation with RNase was due to an association of PI molecules with 
DNA indicative for an uptake into the nucleus. It could be shown that after a pre-incubation 
with RNase and a subsequent 4-hour-incubation with PI-labelled nanoparticles with a size of 
21 nm, 6% of Caco-2 cells were labelled in PI indicative for a nuclear uptake. In contrast, 
13% of the cells were positive for a PI staining without any addition of RNase.  
 
The carrier function of silica nanoparticles could be demonstrated by comparing the cellular 
uptake of free PI and nanoparticle-bound PI. Free PI was not able to enter Caco-2 cells, 
whereas PI bound to silica nanoparticles showed a clear time-dependent internalization.  
 
The nanoparticle labelling with PI further allowed the identification of the cellular 
endocytosis mechanisms involved in the uptake of nanoparticles in a quantitative way. 
Therefore, Caco-2 cells were incubated with different endocytosis inhibitors. Chlorpromazine 
(clathrin-dependent endocytosis) and nystatin (caveolae-dependent endocytosis) showed no 
inhibition in the uptake rate of nanoparticles when compared to cells pre-incubated without an 
inhibitor. Cytochalasin D (phagocytosis) and monensin (clathrin- and caveolae-independent 
pathways) demonstrated a concentration-dependent inhibition in the uptake of nanoparticles. 
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Furthermore, this inhibition was dependent on the used nanoparticle size. The uptake of silica 
nanoparticles with a size of 21 nm were not influenced by these endocytosis inhibitors, 
whereas nanoparticles with a size of 34 and 84 nm showed a strong influence by 
cytochalasin D or monensin. Uptake experiments at a temperature of 4°C further 
demonstrated, that smaller particles were internalized via passive processes, whereas particles 
with a size of 84 nm used active pathways to enter the cells.  
 
As pharmaceutical or medical used silica nanoparticles come into a close contact with 
biological systems, it is essential to evaluate their oxidative and cytotoxic potential. 
Therefore, a novel method for the combined detection of oxidative stress and cytotoxicity was 
established. This assay is based on the automated non-invasive online monitoring of the 
oxygen concentration in solution (SensorDish® Reader). Cellular respiration is associated 
with a consumption of oxygen and therefore serves as an indicator for cytotoxicity and can be 
determined measuring the long-term cellular consumption of oxygen during cell incubation. 
An increase in air saturation caused by decreased cellular consumption of oxygen is a very 
early indication for cytotoxicity. The generation of reactive oxygen species could be analysed 
via the increase in molecular oxygen due to the involvement of antioxidant defence enzymes. 
Silica nanoparticles with different sizes and surface modifications were investigated with this 
novel method concerning their oxidative and cytotoxic potential. Thereby, size, time, 
concentration as well as surface modification of nanoparticles affected the cellular viability 
but not oxidative stress levels. Results of this cytotoxicity studies correlate with performed 
cell association and uptake experiments. RITC-labelled silica nanoparticles with a size of 
50 nm caused a clear decrease in cellular viability over time and had been also described to 
enter Caco-2 cells time-dependently. In contrast, nanoparticles which showed no association 
with cells exhibited no cytotoxic potential. Similar results could be demonstrated for PI-
labelled nanoparticles, where the uptake rate showed a high correlation with the observed 
cytotoxic effect of these particles. Furthermore, it could be shown that the occurred 
cytotoxicity was not reversible within 72 hours.  
 
 
  
 
7 
Outlook 
 
 
Results of this thesis show that silica nanoparticles have a potential as oral drug carriers. 
Dependent on their size and surface modification, silica nanoparticles exhibit a strong 
association with epithelial cells and can be internalized and finally transported across a cell 
monolayer. Especially, the transport across a cellular barrier is essential in the oral 
administration of these carriers. Nanoparticles have to cross the intestinal epithelium to reach 
their target site somewhere else in the body. The manner of the nanoparticulate overcoming of 
such a barrier is therefore an important research topic. Hitherto, it is known, that the transport 
across the intestinal epithelial barrier is not mainly occurring in enterocytes but in the 
intestinal M cell and the follicle associated epithelium. A recent study already introduced a 
novel in vitro model for the human intestinal follicle associated epithelium which could help 
investigating the passage of nanoparticles across the intestinal barrier more detailed (des 
Rieux et al., 2005). The uptake of nanoparticles becomes important once particles have 
reached the target tissue or cells of e.g. a tumour. Thereby, it could be shown that a surface 
modification with PEG is not the best solution because nanoparticles could not bind to cells 
anymore and therefore could not be internalized. In contrast, once reaching the blood 
circulation, the characteristics of PEG are essential. A surface modification with PEG avoids a 
clearance by macrophages and other cells of the immune system and therefore, prolongs the 
retention time of nanoparticles in the blood. Thus, the improvement of the nanoparticulate 
surface modification is a necessary task. An indication could be the functionalization of the 
particle surface with markers or antibodies adequate to specialized cells. M-cells of the gut 
e.g. produce GP2 proteins as receptors on their surface that bind E. coli or salmonella bacteria 
(Terahara et al., 2008). Tumour genes are widely explored and collected in data bases. 
Prominent examples are the human epidermal growth factor receptor 2 (HER-2) in breast 
cancer and the Wilms’ tumour gene 1 (WT-1) which is overexpressed in 70-90 % of acute
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leukaemias (Olayioye, 2001; Boublikova et al., 2006). The intelligent combination of all these 
surface modifications would allow a targeted and efficient transport of nanoparticles. 
 
The loading of nanoparticles with drugs would be the next step in research. This thesis 
investigates silica nanoparticles as a carrier system loaded with fluorescence dyes. Thereby, 
these labellings were core-loaded (RITC) or adsorbed to the particle surface (PI). Drug 
molecules would be bound to nanoparticles in a similar manner. Experiments with PI-labelled 
nanoparticles already showed that silica nanoparticles served as carriers to facilitate the 
cellular uptake of the membrane-impermeable dye PI.  
 
Spherical silica nanoparticles had been already loaded with the poorly, water soluble drug 
telmisartan (Zhang et al., 2010). A further study described an oral delivery system for 
indomethicin engineered from cationic lipid emulsions and silica nanoparticles (Simovic et 
al., 2010). Mesoporous silica nanoparticles (MSN) have been demonstrated to be able to 
deliver kinds of model substances such as fluorescein, Texas Red and rhodamine B. The 
loading was in the order of hundred milligrams per gram of nanoparticles (Slowing et al., 
2008). A MSN-based system was also used to deliver genes in cells. Therefore, the delivery 
system was complexed with a plasmid DNA that encodes for an enhanced green fluorescence 
protein (GFP). Furthermore, this material allows membrane-impermeable molecules, such as 
pharmaceutical drugs and fluorescent dyes, to be encapsulated inside the MSN channels 
(Radu et al., 2004). Other studies showed a release of drugs such as ibuprofen, erythromycin 
and alendronate from MSN as well using different strategies to modify the control of drug 
release (Balas et al., 2006; Lu et al., 2004; Vallet-Regi et al., 2006). A silica-lipid hybrid 
microcapsule system was used for the encapsulation of celecoxib classified as a BCS Class 
II drug (poor solubility, high permeability) that is practically insoluble at gastrointestinal pH 
(Tan et al., 2009). More complex delivery systems allow e.g. a glucose-responsive controlled 
release of insulin and cyclic AMP (Zhao et al., 2009).  
 
The important question concerning all these applications is still, where silica nanoparticles 
remain after administration. Hitherto, there is a lack of publications dealing with the fate of 
silica nanoparticles. A study of Wu et al. described the biodegradation of amorphous silica 
shells merged with superparamagnetic iron oxide nanoparticles. After injection into mice, 
nanoparticles were cleared from the kidney within 2 hours followed by an accumulation in the 
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liver and spleen (Wu et al., 2008). However, the findings about fate and behaviour in the body 
are essential and require intensive research in the future. 
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5ASA  5-Amino salicylic acid 
BCS  Biopharmaceutic classification system 
BSA  Bovine serum albumin 
CLSM  Confocal laser scanning microscopy 
DAPI  4’6’-diamidino-2-phenylindole 
DCF  dichlorofluorescein 
DCF-DA 2’,7’-dichlorofluorescein diacetate  
DDC  Sodium diethyldithiocarbamate trihydrate 
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DLS  Dynamic light scattering 
DMEM Dulbecco’s modified eagle medium 
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FACS  Fluorescence activated cell sorting 
FCS  Fetal calf serum 
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FSC  Forward scatter 
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HBSS  Hank’s balanced salt solution 
HER-2  Human epidermal growth factor receptor 2 
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MSN  Mesoporous silica nanoparticles 
MTT  Thiazolyl blue tetrazolium bromide 
PBS  Phosphate buffered saline 
PEG  Poly ethylene glycol 
PEI  Polyethylenimine 
P-gp  P-glycoprotein 
PI  Propidium iodide 
RITC  Rhodamine B-isothiocyanate 
RNA  Ribonucleic acid 
RNase  Ribonuclease 
ROS  Reactive oxygen species 
SD  Standard derivation 
SDR  SensorDish® Reader 
SOD  Superoxide dismutase 
SSC  Sideward scatter 
TEER  Transepithelial electrical resistance 
TEM  Transmission electron microscopy 
TEOS  Tetraethylorthosilicate 
WGA  wheat germ agglutinin 
WT-1  Wilms’ tumour gene 1 
ζ  Zeta 
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